MCID: ENC018
MIFTS: 61

Encephalopathy

Categories: Eye diseases, Genetic diseases, Immune diseases, Metabolic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Encephalopathy

MalaCards integrated aliases for Encephalopathy:

Name: Encephalopathy 53 53 29 54 6 39
Encephalopathies 71
Brain Diseases 71

Classifications:



External Ids:

ICD10 32 G93.4
UMLS 71 C0006111 C0085584

Summaries for Encephalopathy

NINDS : 53 Aicardi-Goutieres syndrome (AGS) is an inherited encephalopathy that affects newborn infants and usually results in severe mental and physical handicap. There are two forms of the syndrome: an early-onset form that is severe, and a late-onset form that has less impact upon neurological function. The early-onset form affects about 20 percent of all babies who have AGS. These infants are born with neurological and liver abnormalities, such as enlargement of the liver and spleen and elevated liver enzymes. Their jittery behavior and poor feeding ability mimic congenital viral infection. Babies with later-onset AGS begin having symptoms after the first weeks or months of normal development, which appear as a progressive decline in head growth, weak or stiffened muscles (spasticity), and cognitive and developmental delays that range from moderate to severe. Symptoms last for several months, and include irritability, inconsolable crying, intermittent fever, seizures, and loss of developmental skills. Children may also have puffy swelling on the fingers, toes, and ears that resemble chilblains. A number of children have a noticeable startle reaction to sudden noise. For babies with the later-onset form, as symptoms lessen, there is no further worsening of the disease. AGS is difficult to diagnose since many of the symptoms are similar to those of other disorders. Diagnosis is made based on the clinical symptoms of the disease, as well as characteristic brain abnormalities that can be seen in an MRI brain scan. Cerebrospinal fluid (CSF), taken using a "spinal tap," can also be tested for increased levels of a specific immune system cell (a lymphocyte), which indicates a condition known as chronic lymphocytosis. These cells are normally only elevated during infection, so that lymphocytosis without evidence of infection can be used as an indicator of AGS. CSF may also be tested for elevated levels of a substance known as interferon-gamma, which can also support a diagnosis of AGS. The mutations of four different genes are associated with AGS: Aicardi-Goutieres syndrome-1 (AGS1) and AGS5 (an autosomal dominant form) are caused by a mutation in the TREX1 gene, AGS2 is caused by a mutation in the RNASEH2B gene, AGS3 is caused by a mutation in the RNASEH2C gene, AGS4 is caused by a mutation in the RNASEH2A gene. Most cases of AGS are inherited in an autosomal recessive manner, which means that both parents of a child with AGS must carry a single copy of the defective gene responsible for the disease. Parents do not have any symptoms of disease, but with every child they have together, there is a one in four chance that the baby will receive two copies of the defective gene and inherit AGS. NOTE: AGS is distinct from the similarly named Aicardi syndrome (characterized by absence of a brain structure (corpus callosum), and spinal, skeletal, and eye abnormalities).

MalaCards based summary : Encephalopathy, also known as encephalopathies, is related to epileptic encephalopathy, early infantile, 13 and epileptic encephalopathy, early infantile, 17, and has symptoms including seizures, ataxia and myoclonus. An important gene associated with Encephalopathy is SCN1A (Sodium Voltage-Gated Channel Alpha Subunit 1), and among its related pathways/superpathways is Neuroscience. The drugs Magnesium oxide and Tranexamic Acid have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and testes, and related phenotypes are behavior/neurological and nervous system

Wikipedia : 74 Encephalopathy (/ɛnˌsɛfəˈlɒpəθi/; from Ancient Greek: ἐνκέφαλος "brain" + πάθος "suffering") means any... more...

Related Diseases for Encephalopathy

Diseases in the Encephalopathy family:

Encephalopathy Due to Defective Mitochondrial and Peroxisomal Fission 1 Encephalopathy Due to Defective Mitochondrial and Peroxisomal Fission 2
Encephalopathy Due to Mitochondrial and Peroxisomal Fission Defect

Diseases related to Encephalopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2236, show less)
# Related Disease Score Top Affiliating Genes
1 epileptic encephalopathy, early infantile, 13 34.4 SCN1A CDKL5
2 epileptic encephalopathy, early infantile, 17 34.3 MECP2 GNAO1
3 epileptic encephalopathy, early infantile, 1 34.2 SLC25A22 SCN1A GNAO1
4 epileptic encephalopathy, early infantile, 14 34.2 SCN1A MECP2 CDKL5
5 epileptic encephalopathy, early infantile, 9 34.1 STXBP1 SCN1A PCDH19 CDKL5
6 epileptic encephalopathy, early infantile, 4 34.1 STXBP1 CDKL5
7 encephalopathy due to defective mitochondrial and peroxisomal fission 1 34.0 SCN1A MECP2 DNM1L CDKL5
8 early myoclonic encephalopathy 33.8 STXBP1 SLC25A22 SCN1A PCDH19 CDKL5
9 epileptic encephalopathy, early infantile, 6 33.7 STXBP1 SLC25A22 SCN1A PCDH19 MECP2 CDKL5
10 malignant migrating partial seizures of infancy 33.3 SLC25A22 SCN1A
11 epilepsy, focal, with speech disorder and with or without mental retardation 33.2 SPTAN1 FRRS1L
12 undetermined early-onset epileptic encephalopathy 33.2 STXBP1 SLC13A5 NECAP1 AP3B2
13 febrile infection-related epilepsy syndrome 33.1 SCN1A PCDH19
14 lennox-gastaut syndrome 32.9 STXBP1 SLC25A22 SCN1A PCDH19 MECP2 CDKL5
15 west syndrome 32.4 STXBP1 SPTAN1 SLC25A22 SCN1A PCDH19 MECP2
16 aicardi syndrome 32.3 PCDH19 CDKL5
17 landau-kleffner syndrome 32.2 STXBP1 SCN1A PCDH19 MECP2
18 benign familial neonatal epilepsy 32.2 STXBP1 SCN1A PCDH19 CDKL5
19 rett syndrome 32.1 STXBP1 SCN1A MECP2 CDKL5
20 kohlschutter-tonz syndrome 31.9 SLC13A5 SERPINI1
21 early infantile epileptic encephalopathy 31.9 STXBP1 SPTAN1 SLC25A22 SLC13A5 SCN1A PCDH19
22 status epilepticus 31.5 SCN1A PCDH19 DNM1L
23 visual epilepsy 30.9 STXBP1 SPTAN1 SLC13A5 SCN1A MECP2 FRRS1L
24 chorea, childhood-onset, with psychomotor retardation 30.9 GNAO1 FRRS1L
25 focal epilepsy 30.6 SPTAN1 SCN1A PCDH19 MECP2 CDKL5
26 generalized epilepsy with febrile seizures plus 30.2 STXBP1 SCN1A PCDH19 CDKL5
27 benign neonatal seizures 30.2 STXBP1 SLC25A22 SCN1A PCDH19 CDKL5
28 epilepsy 30.1 STXBP1 SPTAN1 SLC25A22 SERPINI1 SCN1A PCDH19
29 bruxism 30.0 STXBP1 MECP2 CDKL5
30 gait apraxia 30.0 PRNP MECP2 CDKL5
31 benign epilepsy with centrotemporal spikes 29.8 STXBP1 SPTAN1 SCN1A PCDH19 MECP2 CDKL5
32 epilepsy with generalized tonic-clonic seizures 29.8 SCN1A CDKL5
33 epilepsy, myoclonic juvenile 29.8 STXBP1 SCN1A PCDH19 CDKL5
34 pervasive developmental disorder 29.7 STXBP1 SCN1A PCDH19 MECP2 CDKL5
35 autosomal dominant nocturnal frontal lobe epilepsy 29.7 STXBP1 SCN1A PCDH19
36 electroclinical syndrome 29.7 STXBP1 SLC25A22 SCN1A PCDH19 MECP2 CDKL5
37 benign familial infantile epilepsy 29.6 STXBP1 SCN1A PCDH19 CDKL5
38 epilepsy, idiopathic generalized 29.5 STXBP1 SCN1A PCDH19 CDKL5
39 lubs x-linked mental retardation syndrome 29.5 MECP2 CDKL5
40 wernicke encephalopathy 12.6
41 encephalopathy, ethylmalonic 12.6
42 hepatic encephalopathy 12.6
43 hypertensive encephalopathy 12.5
44 3-methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome 12.5
45 encephalopathy, familial, with neuroserpin inclusion bodies 12.5
46 glycine encephalopathy 12.5
47 stxbp1 encephalopathy with epilepsy 12.5
48 epileptic encephalopathy, early infantile, 2 12.5
49 mecp2-related severe neonatal encephalopathy 12.5
50 encephalopathy, acute, infection-induced 4 12.5
51 epileptic encephalopathy, early infantile, 7 12.5
52 acute necrotizing encephalopathy type 1 12.5
53 epileptic encephalopathy, early infantile, 12 12.5
54 epileptic encephalopathy, early infantile, 3 12.4
55 epileptic encephalopathy, early infantile, 8 12.4
56 epileptic encephalopathy, early infantile, 50 12.4
57 encephalopathy, neonatal severe, due to mecp2 mutations 12.4
58 scn8a-related epilepsy with encephalopathy 12.4
59 epileptic encephalopathy, childhood-onset 12.4
60 epileptic encephalopathy, early infantile, 26 12.4
61 epileptic encephalopathy, early infantile, 15 12.4
62 epileptic encephalopathy, early infantile, 27 12.4
63 epileptic encephalopathy, early infantile, 29 12.4
64 epileptic encephalopathy, early infantile, 28 12.4
65 epileptic encephalopathy, early infantile, 23 12.4
66 epileptic encephalopathy, early infantile, 5 12.4
67 epileptic encephalopathy, early infantile, 11 12.4
68 epileptic encephalopathy, early infantile, 25, with amelogenesis imperfecta 12.4
69 epileptic encephalopathy, early infantile, 33 12.4
70 mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes 12.4
71 epileptic encephalopathy, early infantile, 24 12.4
72 epileptic encephalopathy, early infantile, 18 12.4
73 epileptic encephalopathy, early infantile, 16 12.4
74 glycine encephalopathy with normal serum glycine 12.4
75 epileptic encephalopathy, early infantile, 37 12.4
76 epileptic encephalopathy, early infantile, 54 12.4
77 epileptic encephalopathy, early infantile, 55 12.4
78 epileptic encephalopathy, early infantile, 31 12.4
79 epileptic encephalopathy, early infantile, 35 12.4
80 epileptic encephalopathy, early infantile, 44 12.4
81 epileptic encephalopathy, early infantile, 47 12.4
82 epileptic encephalopathy, early infantile, 32 12.4
83 epileptic encephalopathy, early infantile, 38 12.4
84 epileptic encephalopathy, early infantile, 61 12.4
85 epileptic encephalopathy, early infantile, 62 12.4
86 epileptic encephalopathy, early infantile, 65 12.4
87 epileptic encephalopathy, early infantile, 39 12.4
88 epileptic encephalopathy, early infantile, 30 12.4
89 epileptic encephalopathy, early infantile, 34 12.4
90 epileptic encephalopathy, early infantile, 53 12.4
91 epileptic encephalopathy, early infantile, 21 12.4
92 encephalitis/encephalopathy, mild, with reversible myelin vacuolization 12.4
93 epileptic encephalopathy, early infantile, 71 12.4
94 epileptic encephalopathy, early infantile, 19 12.4
95 epileptic encephalopathy, early infantile, 45 12.4
96 epileptic encephalopathy, early infantile, 59 12.4
97 epileptic encephalopathy, early infantile, 41 12.4
98 epileptic encephalopathy, early infantile, 42 12.4
99 epileptic encephalopathy, early infantile, 43 12.4
100 epileptic encephalopathy, early infantile, 46 12.4
101 epileptic encephalopathy, early infantile, 36 12.4
102 epileptic encephalopathy, early infantile, 48 12.4
103 epileptic encephalopathy, early infantile, 49 12.4
104 epileptic encephalopathy, early infantile, 51 12.4
105 epileptic encephalopathy, early infantile, 52 12.4
106 epileptic encephalopathy, early infantile, 56 12.4
107 epileptic encephalopathy, early infantile, 57 12.4
108 epileptic encephalopathy, early infantile, 58 12.4
109 epileptic encephalopathy, early infantile, 60 12.4
110 epileptic encephalopathy, early infantile, 66 12.4
111 epileptic encephalopathy, early infantile, 83 12.4
112 epileptic encephalopathy, early infantile, 40 12.4
113 epileptic encephalopathy, early infantile, 63 12.4
114 encephalopathy, progressive, with or without lipodystrophy 12.4
115 epileptic encephalopathy, early infantile, 76 12.4
116 encephalopathy due to defective mitochondrial and peroxisomal fission 2 12.4
117 encephalopathy, progressive, early-onset, with brain atrophy and spasticity 12.4
118 epileptic encephalopathy, infantile or early childhood, 2 12.4
119 epileptic encephalopathy, early infantile, 64 12.4
120 encephalopathy, progressive, with amyotrophy and optic atrophy 12.4
121 epileptic encephalopathy, infantile or early childhood, 1 12.4
122 acute encephalopathy with biphasic seizures and late reduced diffusion 12.4
123 encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 12.4
124 epileptic encephalopathy, early infantile, 74 12.4
125 epileptic encephalopathy, early infantile, 82 12.4
126 encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum 12.4
127 epileptic encephalopathy, early infantile, 73 12.4
128 inflammatory bowel disease, immunodeficiency, and encephalopathy 12.4
129 hashimoto encephalopathy 12.3
130 epileptic encephalopathy, early infantile, 67 12.3
131 epileptic encephalopathy, early infantile, 68 12.3
132 epileptic encephalopathy, early infantile, 69 12.3
133 epileptic encephalopathy, early infantile, 72 12.3
134 encephalopathy, acute, infection-induced 9 12.3
135 epileptic encephalopathy, early infantile, 75 12.3
136 epileptic encephalopathy, early infantile, 84 12.3
137 epileptic encephalopathy, infantile or early childhood, 3 12.3
138 epileptic encephalopathy, early infantile, 70 12.3
139 epileptic encephalopathy, early infantile, 77 12.3
140 epileptic encephalopathy, early infantile, 80 12.3
141 epileptic encephalopathy, early infantile, 81 12.3
142 tango2-related metabolic encephalopathy and arrhythmias 12.3
143 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 12.3
144 toxic encephalopathy 12.3
145 epileptic encephalopathy, early infantile, 78 12.3
146 epileptic encephalopathy, early infantile, 79 12.3
147 spongiform encephalopathy with neuropsychiatric features 12.3
148 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 12.3
149 infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations 12.3
150 hemorrhagic shock and encephalopathy syndrome 12.3
151 encephalopathy, acute, infection-induced 2 12.3
152 subcortical arteriosclerotic encephalopathy 12.2
153 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 12.2
154 encephalopathy, acute, infection-induced 1 12.2
155 encephalopathy, acute, infection-induced 5 12.2
156 encephalopathy, acute, infection-induced 6 12.2
157 encephalopathy, acute, infection-induced 7 12.2
158 encephalopathy, acute, infection-induced 8 12.2
159 prion disease 12.2
160 encephalopathy with intracranial calcification, growth hormone deficiency, microcephaly, and retinal degeneration 12.1
161 creutzfeldt-jakob disease 12.1
162 diabetic encephalopathy 12.1
163 familial acute necrotizing encephalopathy 12.1
164 epileptic encephalopathy, early infantile, 85, with or without midline brain defects 12.1
165 delayed encephalopathy due to carbon monoxide poisoning 12.1
166 encephalopathy, recurrent, of childhood 12.1
167 lethal neonatal spasticity-epileptic encephalopathy syndrome 12.1
168 chd2-related neurodevelopmental disorders 12.1
169 aicardi-goutieres syndrome 12.0
170 acute bilirubin encephalopathy 12.0
171 chronic bilirubin encephalopathy 12.0
172 peho syndrome 12.0
173 myoclonic encephalopathy of infants 12.0
174 mitochondrial dna depletion syndrome 4b 12.0
175 glyt1 encephalopathy 12.0
176 macrocephaly and epileptic encephalopathy 12.0
177 epileptic encephalopathy, early infantile, 86 12.0
178 acute encephalopathy with inflammation-mediated status epilepticus 12.0
179 peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and spongy degeneration of brain 12.0
180 gnb1 encephalopathy 12.0
181 early-onset progressive encephalopathy with migrant continuous myoclonus 12.0
182 atypical glycine encephalopathy 12.0
183 congenital axonal neuropathy with encephalopathy 12.0
184 gerstmann-straussler disease 12.0
185 pyridoxamine 5-prime-phosphate oxidase deficiency 12.0
186 microcephaly, seizures, and developmental delay 12.0
187 neurodegeneration with brain iron accumulation 5 12.0
188 myoclonic epilepsy in non-progressive encephalopathies 12.0
189 thiamine metabolism dysfunction syndrome 2 12.0
190 wernicke-korsakoff syndrome 12.0
191 encephalopathy, axonal, with necrotizing myopathy, cardiomyopathy, and cataracts 11.9
192 arx-related epileptic encephalopathy 11.9
193 early-onset epileptic encephalopathy and intellectual disability due to grin2a mutation 11.9
194 autoimmune encephalopathy with parasomnia and obstructive sleep apnea 11.9
195 arx-related encephalopathy-brain malformation spectrum 11.9
196 encephalopathy due to mitochondrial and peroxisomal fission defect 11.9
197 mitochondrial dna depletion syndrome 13 11.9
198 multiple congenital anomalies-hypotonia-seizures syndrome 2 11.9
199 congenital disorder of glycosylation, type iim 11.9
200 carbonic anhydrase va deficiency, hyperammonemia due to 11.8
201 crome syndrome 11.8
202 dementia pugilistica 11.8
203 pontocerebellar hypoplasia, type 6 11.8
204 glut1 deficiency syndrome 1 11.8
205 pontocerebellar hypoplasia, type 4 11.8
206 kuru 11.8
207 mitochondrial complex iii deficiency, nuclear type 1 11.8
208 thiamine metabolism dysfunction syndrome 5 11.8
209 asparagine synthetase deficiency 11.8
210 aicardi-goutieres syndrome 1 11.8
211 sulfite oxidase deficiency, isolated 11.8
212 leigh syndrome 11.8
213 mental retardation, autosomal dominant 31 11.8
214 acute necrotizing encephalitis 11.8
215 hepatic coma 11.8
216 susac syndrome 11.7
217 coenzyme q10 deficiency, primary, 5 11.7
218 mitochondrial neurogastrointestinal encephalomyopathy 11.7
219 carbonic anhydrase va deficiency 11.7
220 kernicterus 11.6
221 mitochondrial dna depletion syndrome 1 11.6
222 grin2b-related neurodevelopmental disorder 11.6
223 2,4-dienoyl-coa reductase deficiency 11.5
224 continuous spike-wave during slow sleep syndrome 11.5
225 korsakoff's amnesic syndrome 11.5
226 liver cirrhosis 11.5
227 neonatal hypoxic and ischemic brain injury 11.5
228 acute liver failure 11.5
229 pyruvate carboxylase deficiency 11.5
230 cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 11.5
231 mitochondrial complex i deficiency, nuclear type 1 11.5
232 hypermethioninemia due to adenosine kinase deficiency 11.5
233 maple syrup urine disease 11.5
234 aminoacylase 1 deficiency 11.5
235 slc35a2-congenital disorder of glycosylation 11.5
236 segawa syndrome, autosomal recessive 11.5
237 adenylosuccinase deficiency 11.5
238 mitochondrial dna depletion syndrome 7 11.5
239 combined d-2- and l-2-hydroxyglutaric aciduria 11.5
240 syngap1-related intellectual disability 11.4
241 scrapie 11.4
242 mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes 11.4
243 cerebral beriberi 11.4
244 alcohol-related neurodevelopmental disorder 11.4
245 fumarase deficiency 11.4
246 congenital disorder of glycosylation, type ia 11.4
247 carnitine deficiency, systemic primary 11.4
248 hyperornithinemia-hyperammonemia-homocitrullinuria syndrome 11.4
249 ohtahara syndrome 11.4
250 dementia 11.4
251 grin1-related neurodevelopmental disorder 11.4
252 beriberi 11.4
253 pitt-hopkins syndrome 11.4
254 mitochondrial dna depletion syndrome 8a 11.4
255 glucose transporter type 1 deficiency syndrome 11.4
256 5q31.3 microdeletion syndrome 11.4
257 reye syndrome 11.3
258 alcoholic liver cirrhosis 11.3
259 epilepsy, pyridoxine-dependent 11.3
260 cerebellar atrophy with seizures and variable developmental delay 11.3
261 molybdenum cofactor deficiency 11.3
262 coenzyme q10 deficiency disease 11.3
263 combined oxidative phosphorylation deficiency 11.3
264 argininemia 11.3
265 epilepsy with bilateral occipital calcifications 11.3
266 hydroxykynureninuria 11.3
267 d-2-hydroxyglutaric aciduria 1 11.3
268 coenzyme q10 deficiency, primary, 1 11.3
269 combined oxidative phosphorylation deficiency 1 11.3
270 3-methylglutaconic aciduria, type vii 11.3
271 pre-eclampsia 11.3
272 alcohol use disorder 11.3
273 chronic wasting disease 11.3
274 peho-like syndrome 11.2
275 biotin-thiamine-responsive basal ganglia disease 11.2
276 slc12a5-related epilepsy of infancy with migrating focal seizures 11.2
277 foxg1 syndrome 11.2
278 hepatorenal syndrome 11.2
279 kcnq2-related disorders 11.2
280 central nervous system disease 11.2
281 alcoholic hepatitis 11.2
282 periventricular leukomalacia 11.2
283 aids dementia complex 11.2
284 ornithine transcarbamylase deficiency, hyperammonemia due to 11.2
285 dyskinetic cerebral palsy 11.2
286 congenital extrahepatic portosystemic shunt 11.2
287 mitochondrial dna depletion syndrome 4a 11.2
288 cerebellar degeneration 11.2
289 lissencephaly 11.2
290 fars2 deficiency 11.2
291 acyl-coa dehydrogenase, medium-chain, deficiency of 11.2
292 rigidity and multifocal seizure syndrome, lethal neonatal 11.2
293 hepatitis, fulminant viral 11.2
294 seizures, benign familial neonatal, 1 11.2
295 crigler-najjar syndrome, type i 11.2
296 lissencephaly 1 11.2
297 mental retardation, autosomal dominant 6, with or without seizures 11.2
298 alpha-methylacyl-coa racemase deficiency 11.2
299 neurodevelopmental disorder with involuntary movements 11.2
300 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 11.2
301 hyperekplexia 4 11.2
302 gerstmann syndrome 11.2
303 hyper-beta-alaninemia 11.2
304 cerebral creatine deficiency syndrome 1 11.2
305 mitochondrial complex i deficiency, mitochondrial type 1 11.2
306 combined oxidative phosphorylation deficiency 4 11.2
307 chromosome 15q13.3 deletion syndrome 11.2
308 hyperglycinemia, lactic acidosis, and seizures 11.2
309 infantile cerebellar-retinal degeneration 11.2
310 mitochondrial complex iii deficiency, nuclear type 8 11.2
311 mental retardation, autosomal recessive 49 11.2
312 combined oxidative phosphorylation deficiency 27 11.2
313 mitochondrial complex v deficiency, nuclear type 5 11.2
314 mitochondrial complex i deficiency, nuclear type 7 11.2
315 mitochondrial complex i deficiency, nuclear type 10 11.2
316 mitochondrial complex i deficiency, nuclear type 19 11.2
317 metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression 11.2
318 lipoic acid synthetase deficiency 11.2
319 neonatal adrenoleukodystrophy 11.2
320 scn2a related disorders 11.2
321 epilepsy-aphasia spectrum 11.2
322 combined saposin deficiency 11.1
323 mitochondrial complex iii deficiency 11.1
324 urocanase deficiency 11.0
325 gaucher disease, type iii 11.0
326 cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss 11.0
327 3-hydroxy-3-methylglutaryl-coa synthase-2 deficiency 11.0
328 gaba-transaminase deficiency 11.0
329 thiamine metabolism dysfunction syndrome 4 11.0
330 multiple mitochondrial dysfunctions syndrome 11.0
331 visceral myopathy, familial, with external ophthalmoplegia 10.9
332 pura-related neurodevelopmental disorders 10.9
333 horizontal gaze palsy with progressive scoliosis 10.9
334 leigh syndrome with leukodystrophy 10.9
335 leigh syndrome with nephrotic syndrome 10.9
336 progressive dementia with neuroserpin inclusion bodies 10.9
337 progressive myoclonic epilepsy with neuroserpin inclusion bodies 10.9
338 ravine syndrome 10.9
339 ocular motor apraxia 10.9
340 ceroid lipofuscinosis, neuronal, 2 10.8
341 argininosuccinic aciduria 10.8
342 carbamoyl phosphate synthetase i deficiency, hyperammonemia due to 10.8
343 methemoglobinemia due to deficiency of methemoglobin reductase 10.8
344 pseudo-torch syndrome 1 10.8
345 mitochondrial dna depletion syndrome 3 10.8
346 tricarboxylic acid cycle, defect of 10.8
347 mental retardation, x-linked, syndromic 13 10.8
348 mitochondrial complex i deficiency, nuclear type 12 10.8
349 mitochondrial complex i deficiency, nuclear type 30 10.8
350 mitochondrial complex v deficiency, nuclear type 1 10.8
351 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 10.8
352 crigler-najjar syndrome, type ii 10.8
353 microcephaly, amish type 10.8
354 glutamine deficiency, congenital 10.8
355 aicardi-goutieres syndrome 3 10.8
356 leukoencephalopathy, cystic, without megalencephaly 10.8
357 d-2-hydroxyglutaric aciduria 2 10.8
358 generalized epilepsy with febrile seizures plus, type 8 10.8
359 mitochondrial complex v deficiency, nuclear type 3 10.8
360 coenzyme q10 deficiency, primary, 3 10.8
361 mitochondrial pyruvate carrier deficiency 10.8
362 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 10.8
363 maple syrup urine disease, mild variant 10.8
364 mitochondrial complex iii deficiency, nuclear type 2 10.8
365 mitochondrial complex iii deficiency, nuclear type 3 10.8
366 mitochondrial complex iii deficiency, nuclear type 4 10.8
367 combined oxidative phosphorylation deficiency 22 10.8
368 immunodeficiency 44 10.8
369 immunodeficiency 45 10.8
370 mitochondrial dna depletion syndrome 14 10.8
371 neurodevelopmental disorder with hypotonia, seizures, and absent language 10.8
372 mitochondrial complex i deficiency, nuclear type 2 10.8
373 mitochondrial complex i deficiency, nuclear type 4 10.8
374 mitochondrial complex i deficiency, nuclear type 6 10.8
375 mitochondrial complex i deficiency, nuclear type 8 10.8
376 mitochondrial complex i deficiency, nuclear type 9 10.8
377 mitochondrial complex i deficiency, nuclear type 11 10.8
378 mitochondrial complex i deficiency, nuclear type 13 10.8
379 mitochondrial complex i deficiency, nuclear type 14 10.8
380 mitochondrial complex i deficiency, nuclear type 15 10.8
381 mitochondrial complex i deficiency, nuclear type 16 10.8
382 mitochondrial complex i deficiency, nuclear type 17 10.8
383 mitochondrial complex i deficiency, nuclear type 18 10.8
384 mitochondrial complex i deficiency, nuclear type 21 10.8
385 mitochondrial complex i deficiency, nuclear type 22 10.8
386 mitochondrial complex i deficiency, nuclear type 23 10.8
387 mitochondrial complex i deficiency, nuclear type 24 10.8
388 mitochondrial complex i deficiency, nuclear type 25 10.8
389 mitochondrial complex i deficiency, nuclear type 26 10.8
390 mitochondrial complex i deficiency, nuclear type 27 10.8
391 mitochondrial complex i deficiency, nuclear type 28 10.8
392 mitochondrial complex i deficiency, nuclear type 29 10.8
393 mitochondrial complex i deficiency, nuclear type 31 10.8
394 mitochondrial complex i deficiency, nuclear type 32 10.8
395 mitochondrial complex i deficiency, nuclear type 33 10.8
396 congenital disorder of glycosylation with defective fucosylation 2 10.8
397 infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 10.8
398 neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 10.8
399 mitochondrial dna depletion syndrome 17 10.8
400 neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 10.8
401 mitochondrial complex i deficiency, nuclear type 34 10.8
402 seizures, early-onset, with neurodegeneration and brain calcifications 10.8
403 cylindrical spirals myopathy 10.8
404 hepatic veno-occlusive disease 10.8
405 lipoic acid biosynthesis defects 10.8
406 morvan's fibrillary chorea 10.8
407 paroxysmal exertion-induced dyskinesia 10.8
408 scn1a-related seizure disorders 10.8
409 ataxia neuropathy spectrum 10.8
410 myoclonic epilepsy myopathy sensory ataxia 10.8
411 ataxia and polyneuropathy, adult-onset 10.8
412 seizure disorder 10.8
413 encephalitis 10.8
414 myoclonus 10.7
415 lactic acidosis 10.7
416 brain edema 10.6
417 eclampsia 10.6
418 liver disease 10.6
419 cerebral palsy 10.6
420 yemenite deaf-blind hypopigmentation syndrome 10.6
421 myopathy 10.6
422 hypotonia 10.6
423 tremor 10.6
424 alcohol dependence 10.6
425 portal hypertension 10.6
426 headache 10.5
427 thyroiditis 10.5
428 alacrima, achalasia, and mental retardation syndrome 10.5
429 pathologic nystagmus 10.5
430 mitochondrial myopathy 10.5
431 influenza 10.5
432 neuropathy 10.5
433 subacute delirium 10.5
434 microcephaly 10.5
435 hypoglycemia 10.5
436 kearns-sayre syndrome 10.5
437 cortical blindness 10.5
438 cerebral atrophy 10.5
439 vasculitis 10.4
440 traumatic brain injury 10.4
441 hashimoto thyroiditis 10.4
442 brain injury 10.4
443 kidney disease 10.4
444 aphasia 10.4
445 peripheral nervous system disease 10.4
446 varicose veins 10.4
447 hydrocephalus 10.4
448 metabolic acidosis 10.4
449 asphyxia neonatorum 10.4
450 movement disease 10.4
451 dystonia 10.4
452 cardiac arrest 10.4
453 systemic lupus erythematosus 10.4
454 febrile seizures 10.4
455 autoimmune disease 10.4
456 middle east respiratory syndrome 10.4
457 respiratory failure 10.4
458 diarrhea 10.4
459 photosensitive epilepsy 10.4 STXBP1 SCN1A PCDH19
460 polyneuropathy 10.4
461 end stage renal disease 10.4
462 hypothyroidism 10.4
463 lupus erythematosus 10.3
464 hemiplegia 10.3
465 pertussis 10.3
466 intracranial hypertension 10.3
467 leukemia, acute lymphoblastic 10.3
468 mitochondrial disorders 10.3
469 non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy 10.3
470 human immunodeficiency virus type 1 10.3
471 exanthem 10.3
472 head injury 10.3
473 spasticity 10.3
474 guillain-barre syndrome 10.3
475 bilirubin metabolic disorder 10.3
476 glomerulonephritis 10.3
477 acquired immunodeficiency syndrome 10.3
478 esophageal varix 10.3
479 quadriplegia 10.3
480 acute kidney failure 10.3
481 anoxia 10.3
482 partial motor epilepsy 10.3 STXBP1 SLC25A22 SCN1A CDKL5
483 childhood electroclinical syndrome 10.3 STXBP1 SCN1A PCDH19 CDKL5
484 3-methylglutaconic aciduria, type iii 10.3
485 immune deficiency disease 10.3
486 uremia 10.3
487 alzheimer disease 10.3
488 viral hepatitis 10.3
489 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.3
490 choreatic disease 10.3
491 branchiootic syndrome 1 10.3
492 constipation 10.3
493 hyperglycemia 10.3
494 christianson syndrome 10.3 MECP2 CDKL5
495 chorea, benign hereditary 10.3 GNAO1 FRRS1L
496 cat-scratch disease 10.3
497 nephrotic syndrome 10.3
498 toxic shock syndrome 10.3
499 acute pancreatitis 10.3
500 limbic encephalitis 10.3
501 amnestic disorder 10.3
502 inherited metabolic disorder 10.3
503 peritonitis 10.3
504 binswanger's disease 10.3
505 purpura 10.2
506 meningoencephalitis 10.2
507 thrombocytopenia 10.2
508 mutism 10.2
509 neuroblastoma 10.2
510 fatal familial insomnia 10.2
511 malignant hypertension 10.2
512 migraine with or without aura 1 10.2
513 acute cystitis 10.2
514 gastroenteritis 10.2
515 pancreatitis 10.2
516 measles 10.2
517 myeloma, multiple 10.2
518 stroke, ischemic 10.2
519 porphyria 10.2
520 dysphagia 10.2
521 apraxia 10.2
522 meningitis 10.2
523 47,xyy 10.2
524 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.2
525 disseminated intravascular coagulation 10.2
526 viral encephalitis 10.2
527 hypertonia 10.2
528 cerebrovascular disease 10.2
529 mitochondrial encephalomyopathy 10.2
530 overgrowth syndrome 10.2
531 hemolytic-uremic syndrome 10.2
532 acute disseminated encephalomyelitis 10.2
533 specific developmental disorder 10.2 SCN1A MECP2 CDKL5
534 leptin deficiency or dysfunction 10.2
535 mitochondrial metabolism disease 10.2
536 chronic kidney disease 10.2
537 autosomal recessive disease 10.2
538 hyperthyroidism 10.2
539 48,xyyy 10.2
540 porphyria, acute intermittent 10.2
541 sensorineural hearing loss 10.2
542 encephalomalacia 10.2
543 central pontine myelinolysis 10.2
544 chronic fatigue syndrome 10.2
545 fatty liver disease 10.2
546 autoimmune encephalitis 10.2
547 cytokine deficiency 10.2
548 hypoxia 10.2
549 childhood absence epilepsy 10.1 STXBP1 SCN1A PCDH19 CDKL5 CACNA2D2
550 hypokalemia 10.1
551 pellagra 10.1
552 herpes simplex 10.1
553 crohn's disease 10.1
554 chorioamnionitis 10.1
555 chickenpox 10.1
556 reversible cerebral vasoconstriction syndrome 10.1
557 vascular disease 10.1
558 optic nerve disease 10.1
559 nervous system disease 10.1
560 cerebral hypoxia 10.1
561 autism spectrum disorder 10.1
562 thrombosis 10.1
563 papilledema 10.1
564 vascular dementia 10.1
565 rubella 10.1
566 autonomic dysfunction 10.1
567 atrial standstill 1 10.1
568 renal hypertension 10.1
569 graves' disease 10.1
570 dysautonomia 10.1
571 cerebral amyloid angiopathy, cst3-related 10.1
572 amyotrophic lateral sclerosis 1 10.1
573 colorectal cancer 10.1
574 autism 10.1
575 mitochondrial complex iv deficiency 10.1
576 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
577 graves disease 1 10.1
578 helicobacter pylori infection 10.1
579 propionic acidemia 10.1
580 portal vein thrombosis 10.1
581 neutropenia 10.1
582 lateral sclerosis 10.1
583 major affective disorder 8 10.1
584 major affective disorder 9 10.1
585 graft-versus-host disease 10.1
586 polymicrogyria with or without vascular-type ehlers-danlos syndrome 10.1
587 pulmonary hypertension 10.1
588 bipolar disorder 10.1
589 akinetic mutism 10.1
590 bacterial meningitis 10.1
591 mitochondrial dna-associated leigh syndrome and narp 10.1
592 polymicrogyria 10.1
593 pulmonary disease, chronic obstructive 10.1
594 nasopharyngeal carcinoma 10.1
595 diabetes mellitus, ketosis-prone 10.1
596 lymphoma 10.1
597 covid-19 10.1
598 bacterial infectious disease 10.1
599 lyme disease 10.1
600 telangiectasis 10.1
601 acute poststreptococcal glomerulonephritis 10.1
602 normal pressure hydrocephalus 10.1
603 ischemia 10.1
604 toxoplasmosis 10.1
605 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 10.1
606 ptosis 10.1
607 allergic hypersensitivity disease 10.1
608 tuberous sclerosis 10.1
609 obstructive hydrocephalus 10.1
610 arteriosclerosis 10.1
611 sleep disorder 10.1
612 muscular atrophy 10.1
613 thrombophilia due to thrombin defect 10.0
614 japanese encephalitis 10.0
615 spastic quadriplegia 10.0
616 severe pre-eclampsia 10.0
617 hellp syndrome 10.0
618 autosomal dominant cerebellar ataxia 10.0
619 demyelinating disease 10.0
620 paraplegia 10.0
621 progressive multifocal leukoencephalopathy 10.0
622 b-cell lymphoma 10.0
623 axonal neuropathy 10.0
624 neuromyelitis optica 10.0
625 amyloidosis 10.0
626 hypereosinophilic syndrome 10.0
627 athetosis 10.0
628 depression 10.0
629 neonatal period electroclinical syndrome 10.0 STXBP1 SLC25A22 SCN1A PCDH19 MECP2 CDKL5
630 hypertension, essential 10.0
631 body mass index quantitative trait locus 11 10.0
632 body mass index quantitative trait locus 9 10.0
633 body mass index quantitative trait locus 8 10.0
634 body mass index quantitative trait locus 4 10.0
635 body mass index quantitative trait locus 10 10.0
636 body mass index quantitative trait locus 7 10.0
637 body mass index quantitative trait locus 12 10.0
638 body mass index quantitative trait locus 14 10.0
639 body mass index quantitative trait locus 18 10.0
640 body mass index quantitative trait locus 19 10.0
641 body mass index quantitative trait locus 20 10.0
642 deficiency anemia 10.0
643 trypanosomiasis 10.0
644 mumps 10.0
645 hereditary hemorrhagic telangiectasia 10.0
646 hyperparathyroidism 10.0
647 myeloid leukemia 10.0
648 diabetes insipidus 10.0
649 herpes simplex encephalitis 10.0
650 hepatocellular carcinoma 10.0
651 schizophrenia 10.0
652 osteogenic sarcoma 10.0
653 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
654 frontotemporal dementia 10.0
655 leukemia, acute myeloid 10.0
656 sleeping sickness 10.0
657 short bowel syndrome 10.0
658 tetanus 10.0
659 shigellosis 10.0
660 leukemia 10.0
661 pancytopenia 10.0
662 myelitis 10.0
663 urea cycle disorder 10.0
664 tuberculous meningitis 10.0
665 aneurysm 10.0
666 persistent vegetative state 10.0
667 dengue virus 10.0
668 aspiration pneumonia 10.0
669 exanthema subitum 10.0
670 pulmonary edema 10.0
671 diphtheria 10.0
672 dengue hemorrhagic fever 10.0
673 acute leukemia 10.0
674 methylmalonic acidemia 10.0
675 motor neuron disease 10.0
676 substance abuse 10.0
677 temporal lobe epilepsy 10.0
678 poliomyelitis 10.0
679 hemolytic anemia 10.0
680 diabetes mellitus 10.0
681 specific language disorder 10.0
682 infantile epilepsy syndrome 10.0
683 iatrogenic creutzfeldt-jakob disease 10.0
684 schistosoma mansoni infection, susceptibility/ 10.0
685 subacute sclerosing panencephalitis 10.0
686 supranuclear palsy, progressive, 1 10.0
687 hepatitis c virus 10.0
688 inflammatory bowel disease 10.0
689 diffuse large b-cell lymphoma 10.0
690 hyperekplexia 10.0
691 leukodystrophy 10.0
692 bronchopneumonia 10.0
693 chronic progressive external ophthalmoplegia 10.0
694 typhoid fever 10.0
695 schistosomiasis 10.0
696 hepatitis 10.0
697 pneumonia 10.0
698 congestive heart failure 10.0
699 ileus 10.0
700 placental abruption 10.0
701 sickle cell disease 10.0
702 allergic encephalomyelitis 10.0
703 epilepsy with myoclonic-atonic seizures 10.0
704 spastic paraparesis 10.0
705 thunderclap headache 10.0
706 multiple sclerosis 10.0
707 pheochromocytoma 10.0
708 sarcoidosis 1 10.0
709 myxedema 10.0
710 sudden infant death syndrome 10.0
711 cyanosis, transient neonatal 10.0
712 hypophosphatemia 10.0
713 adrenal gland pheochromocytoma 10.0
714 thrombotic thrombocytopenic purpura 10.0
715 rabies 10.0
716 hypertrophic cardiomyopathy 10.0
717 primary biliary cirrhosis 10.0
718 pseudobulbar palsy 10.0
719 neuroleptic malignant syndrome 10.0
720 neonatal jaundice 10.0
721 bronchiolitis 10.0
722 agnosia 10.0
723 myocarditis 10.0
724 retinal degeneration 10.0
725 speech disorder 10.0
726 acute graft versus host disease 10.0
727 hypersomnia 10.0
728 congenital portosystemic shunt 10.0
729 renal cell carcinoma, nonpapillary 9.9
730 ovarian cancer 9.9
731 strabismus 9.9
732 lymphoma, hodgkin, classic 9.9
733 abnormal hair, joint laxity, and developmental delay 9.9
734 meningioma, radiation-induced 9.9
735 anorexia nervosa 9.9
736 meningioma, familial 9.9
737 aplastic anemia 9.9
738 malaria 9.9
739 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.9
740 infantile liver failure syndrome 1 9.9
741 familial hemiplegic migraine 9.9
742 colitis 9.9
743 scoliosis 9.9
744 non-alcoholic fatty liver disease 9.9
745 endocarditis 9.9
746 spinal meningioma 9.9
747 aseptic meningitis 9.9
748 dengue disease 9.9
749 hepatitis a 9.9
750 focal segmental glomerulosclerosis 9.9
751 renovascular hypertension 9.9
752 teratoma 9.9
753 mood disorder 9.9
754 syphilis 9.9
755 dysgraphia 9.9
756 secretory meningioma 9.9
757 lymphoplasmacyte-rich meningioma 9.9
758 intracranial hypotension 9.9
759 fibrolamellar carcinoma 9.9
760 adenoma 9.9
761 mechanical strabismus 9.9
762 polyarteritis nodosa 9.9
763 congenital disorders of n-linked glycosylation and multiple pathway 9.9
764 convulsions benign familial neonatal dominant form 9.9
765 marchiafava bignami disease 9.9
766 myoclonus epilepsy 9.9
767 neonatal stroke 9.9
768 dementia - subcortical 9.9
769 posttransplant acute limbic encephalitis 9.9
770 pik3ca-related overgrowth syndrome 9.9
771 thrombotic microangiopathy 9.9
772 infancy electroclinical syndrome 9.9 STXBP1 SPTAN1 SLC25A22 SCN1A PCDH19 MECP2
773 scleroderma, familial progressive 9.9
774 3-methylglutaconic aciduria, type i 9.9
775 budd-chiari syndrome 9.9
776 anxiety 9.9
777 porencephaly 9.9
778 3-methylglutaconic aciduria 9.9
779 intestinal pseudo-obstruction 9.9
780 neuroretinitis 9.9
781 osteomalacia 9.9
782 spastic diplegia 9.9
783 hypoparathyroidism 9.9
784 cerebral atherosclerosis 9.9
785 cholestasis 9.9
786 mental depression 9.9
787 pericarditis 9.9
788 severe acute respiratory syndrome 9.9
789 systemic scleroderma 9.9
790 connective tissue disease 9.9
791 isolated methylmalonic acidemia 9.9
792 hemimegalencephaly 9.9
793 genetic epilepsy with febrile seizures plus 9.9
794 spinal cord injury 9.9
795 cerebral visual impairment 9.9
796 serotonin syndrome 9.9
797 infectious encephalitis 9.9
798 breast cancer 9.9
799 cardiac arrhythmia 9.9
800 fibromuscular dysplasia 9.9
801 multiple system atrophy 1 9.9
802 tuberous sclerosis 1 9.9
803 wilson disease 9.9
804 incontinentia pigmenti 9.9
805 cyclic vomiting syndrome 9.9
806 lymphoma, non-hodgkin, familial 9.9
807 kawasaki disease 9.9
808 microvascular complications of diabetes 3 9.9
809 microvascular complications of diabetes 4 9.9
810 microvascular complications of diabetes 6 9.9
811 microvascular complications of diabetes 7 9.9
812 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.9
813 cortical dysplasia, complex, with other brain malformations 10 9.9
814 alternating hemiplegia of childhood 9.9
815 organic acidemia 9.9
816 agraphia 9.9
817 migraine with aura 9.9
818 thalassemia 9.9
819 goiter 9.9
820 neuritis 9.9
821 hyperuricemia 9.9
822 rectum cancer 9.9
823 hyperinsulinism 9.9
824 transient cerebral ischemia 9.9
825 agammaglobulinemia 9.9
826 hepatitis e 9.9
827 severe combined immunodeficiency 9.9
828 basal ganglia disease 9.9
829 peptic ulcer disease 9.9
830 intestinal obstruction 9.9
831 ulcerative colitis 9.9
832 alopecia 9.9
833 grin2a-related speech disorders and epilepsy 9.9
834 kcnq3-related disorders 9.9
835 corticobasal degeneration 9.9
836 glioma 9.9
837 paraneoplastic syndromes 9.9
838 paresthesia 9.9
839 spinocerebellar degeneration 9.9
840 syncope 9.9
841 glial tumor 9.9
842 rapidly involuting congenital hemangioma 9.9
843 pfeiffer syndrome 9.8
844 angelman syndrome 9.8
845 huntington disease 9.8
846 attention deficit-hyperactivity disorder 9.8
847 hypercholesterolemia, familial, 1 9.8
848 macular degeneration, age-related, 2 9.8
849 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1 9.8
850 teratoma, ovarian 9.8
851 parkinson disease, late-onset 9.8
852 alexander disease 9.8
853 celiac disease 1 9.8
854 citrullinemia, classic 9.8
855 leukoencephalopathy, hereditary diffuse, with spheroids 9.8
856 enterocolitis 9.8
857 biotinidase deficiency 9.8
858 pancreatic cancer 9.8
859 diabetes and deafness, maternally inherited 9.8
860 sickle cell anemia 9.8
861 major depressive disorder 9.8
862 leukemia, acute lymphoblastic 3 9.8
863 alkuraya-kucinskas syndrome 9.8
864 epidemic typhus 9.8
865 salmonellosis 9.8
866 bone disease 9.8
867 non-alcoholic steatohepatitis 9.8
868 heart disease 9.8
869 pyelonephritis 9.8
870 hypertensive retinopathy 9.8
871 listeriosis 9.8
872 onchocerciasis 9.8
873 dilated cardiomyopathy 9.8
874 acute proliferative glomerulonephritis 9.8
875 personality disorder 9.8
876 hepatitis c 9.8
877 cholecystitis 9.8
878 hepatitis b 9.8
879 psychotic disorder 9.8
880 tic disorder 9.8
881 antiphospholipid syndrome 9.8
882 central nervous system lymphoma 9.8
883 retinitis 9.8
884 polyradiculoneuropathy 9.8
885 anterograde amnesia 9.8
886 ovarian germ cell teratoma 9.8
887 cataract 9.8
888 homocystinuria 9.8
889 episodic ataxia 9.8
890 toxocariasis 9.8
891 mecp2 disorders 9.8
892 nuclear gene-encoded leigh syndrome 9.8
893 pachygyria 9.8
894 pseudobulbar affect 9.8
895 pure autonomic failure 9.8
896 splenomegaly 9.8
897 angiomatosis 9.8
898 extrapontine myelinolysis 9.8
899 acyl-coa dehydrogenase deficiency 9.8
900 congenital amyoplasia 9.8
901 atherosclerosis susceptibility 9.8
902 gastroesophageal reflux 9.8
903 bladder cancer 9.8
904 burkitt lymphoma 9.8
905 fibrosis of extraocular muscles, congenital, 1 9.8
906 hypertriglyceridemia, familial 9.8
907 pick disease of brain 9.8
908 small cell cancer of the lung 9.8
909 down syndrome 9.8
910 lipoid congenital adrenal hyperplasia 9.8
911 lung cancer 9.8
912 hemochromatosis, type 1 9.8
913 insulin-like growth factor i 9.8
914 patent ductus venosus 9.8
915 ascaris lumbricoides infection 9.8
916 hypereosinophilic syndrome, idiopathic 9.8
917 granulomatosis with polyangiitis 9.8
918 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2 9.8
919 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 4 9.8
920 ewing sarcoma 9.8
921 fatty liver disease, nonalcoholic 1 9.8
922 gastric cancer 9.8
923 helix syndrome 9.8
924 hemophagocytic lymphohistiocytosis 9.8
925 variola major 9.8
926 funisitis 9.8
927 vitamin b12 deficiency 9.8
928 lymphoproliferative syndrome 9.8
929 cryptococcal meningitis 9.8
930 neurodegeneration with brain iron accumulation 9.8
931 osteonecrosis 9.8
932 brucellosis 9.8
933 arteriovenous malformation 9.8
934 optic neuritis 9.8
935 pica disease 9.8
936 neurogenic bladder 9.8
937 scrub typhus 9.8
938 facial paralysis 9.8
939 pneumothorax 9.8
940 thrombophilia 9.8
941 kluver-bucy syndrome 9.8
942 dermatitis 9.8
943 pulmonary tuberculosis 9.8
944 glioblastoma multiforme 9.8
945 ascaridiasis 9.8
946 acute porphyria 9.8
947 neurilemmoma 9.8
948 inappropriate adh syndrome 9.8
949 arteriolosclerosis 9.8
950 bronchitis 9.8
951 juvenile rheumatoid arthritis 9.8
952 lung disease 9.8
953 herpes zoster 9.8
954 malignant hyperthermia 9.8
955 smallpox 9.8
956 progressive myoclonus epilepsy 9.8
957 muscular dystrophy 9.8
958 tbc1d24-related disorders 9.8
959 banti's syndrome 9.8
960 iqsec2 9.8
961 precocious puberty 9.8
962 primary central nervous system lymphoma 9.8
963 transverse myelitis 9.8
964 cerebral aneurysms 9.8
965 cytomegalovirus infection 9.8
966 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.8
967 thyroid carcinoma 9.8
968 prune belly syndrome 9.8
969 anisocoria 9.8
970 otitis media 9.8
971 stiff-person syndrome 9.8
972 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
973 diabetes mellitus, type i 9.8
974 glutaric acidemia i 9.8
975 hydrocephalus, congenital, 1 9.8
976 l-2-hydroxyglutaric aciduria 9.8
977 moyamoya disease 1 9.8
978 myasthenia gravis 9.8
979 orotic aciduria 9.8
980 dihydropyrimidine dehydrogenase deficiency 9.8
981 arts syndrome 9.8
982 citrullinemia, type ii, adult-onset 9.8
983 spinocerebellar ataxia 12 9.8
984 late-onset retinal degeneration 9.8
985 leukemia, chronic myeloid 9.8
986 myocardial infarction 9.8
987 west nile virus 9.8
988 myelodysplastic syndrome 9.8
989 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.8
990 hyperprolactinemia 9.8
991 melanoma, cutaneous malignant 10 9.8
992 2-hydroxyglutaric aciduria 9.8
993 oculogyric crisis 9.8
994 auditory agnosia 9.8
995 pain agnosia 9.8
996 basal ganglia calcification 9.8
997 pontocerebellar hypoplasia 9.8
998 autosomal recessive non-syndromic intellectual disability 9.8
999 wet beriberi 9.8
1000 dry beriberi 9.8
1001 cerebellar hypoplasia 9.8
1002 myoglobinuria 9.8
1003 childhood acute lymphocytic leukemia 9.8
1004 asymptomatic neurosyphilis 9.8
1005 cysticercosis 9.8
1006 cerebral artery occlusion 9.8
1007 osteomyelitis 9.8
1008 common cold 9.8
1009 rickets 9.8
1010 cystinosis 9.8
1011 gastric ulcer 9.8
1012 intracranial aneurysm 9.8
1013 meconium aspiration syndrome 9.8
1014 primary hyperparathyroidism 9.8
1015 adult respiratory distress syndrome 9.8
1016 autonomic neuropathy 9.8
1017 gestational diabetes 9.8
1018 clubfoot 9.8
1019 cryptococcosis 9.8
1020 spinal muscular atrophy 9.8
1021 pyloric stenosis 9.8
1022 leiomyoma 9.8
1023 miller fisher syndrome 9.8
1024 hereditary spherocytosis 9.8
1025 carotid stenosis 9.8
1026 megaloblastic anemia 9.8
1027 alexia 9.8
1028 avoidant personality disorder 9.8
1029 lymphadenitis 9.8
1030 hypoglycemic coma 9.8
1031 cystitis 9.8
1032 melanoma 9.8
1033 leiomyosarcoma 9.8
1034 post-traumatic stress disorder 9.8
1035 neuroaxonal dystrophy 9.8
1036 sensory peripheral neuropathy 9.8
1037 cryoglobulinemia 9.8
1038 membranoproliferative glomerulonephritis 9.8
1039 anuria 9.8
1040 astrocytoma 9.8
1041 cellulitis 9.8
1042 pleural empyema 9.8
1043 gastritis 9.8
1044 neuromuscular disease 9.8
1045 retrograde amnesia 9.8
1046 hydranencephaly 9.8
1047 benign ependymoma 9.8
1048 thyroid gland disease 9.8
1049 demyelinating polyneuropathy 9.8
1050 human immunodeficiency virus infectious disease 9.8
1051 cellular ependymoma 9.8
1052 acute stress disorder 9.8
1053 t-cell lymphoblastic leukemia/lymphoma 9.8
1054 parathyroid adenoma 9.8
1055 carotid artery occlusion 9.8
1056 cocaine abuse 9.8
1057 appendicitis 9.8
1058 eating disorder 9.8
1059 neurofibromatosis 9.8
1060 learning disability 9.8
1061 viral infectious disease 9.8
1062 hypopituitarism 9.8
1063 cholangitis 9.8
1064 scn1a seizure disorders 9.8
1065 anca-associated vasculitis 9.8
1066 hhv-6 encephalitis 9.8
1067 leukemia, t-cell, chronic 9.8
1068 macrophage activation syndrome 9.8
1069 neurosyphilis 9.8
1070 nodular regenerative hyperplasia 9.8
1071 polymyositis 9.8
1072 pyridoxine deficiency 9.8
1073 scleromyxedema 9.8
1074 soft tissue sarcoma 9.8
1075 wallerian degeneration 9.8
1076 cryptogenic cirrhosis 9.8
1077 cerebral arteriosclerosis 9.8
1078 infantile hypotonia 9.8
1079 argyria 9.8
1080 myoclonic epilepsy of infancy 9.8
1081 chronic encephalitis 9.8
1082 hereditary optic neuropathy 9.8
1083 cleft palate, isolated 9.7
1084 major affective disorder 1 9.7
1085 kleine-levin hibernation syndrome 9.7
1086 neural tube defects 9.7
1087 triiodothyronine receptor auxiliary protein 9.7
1088 volvulus of midgut 9.7
1089 wolff-parkinson-white syndrome 9.7
1090 takayasu arteritis 9.7
1091 galactosemia i 9.7
1092 homocystinuria due to deficiency of n -methylenetetrahydrofolate reductase activity 9.7
1093 n-acetylglutamate synthase deficiency 9.7
1094 myelofibrosis 9.7
1095 agammaglobulinemia, x-linked 9.7
1096 leber optic atrophy 9.7
1097 pyruvate dehydrogenase e1-alpha deficiency 9.7
1098 myoclonic epilepsy associated with ragged-red fibers 9.7
1099 macular degeneration, age-related, 1 9.7
1100 homocysteinemia 9.7
1101 body mass index quantitative trait locus 1 9.7
1102 gastrointestinal stromal tumor 9.7
1103 aspergillosis 9.7
1104 spinocerebellar ataxia, autosomal recessive 12 9.7
1105 cholangiocarcinoma 9.7
1106 mental retardation, autosomal recessive 42 9.7
1107 corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia 9.7
1108 speech and communication disorders 9.7
1109 bacterial sepsis 9.7
1110 autoimmune vasculitis 9.7
1111 hyperphosphatemia 9.7
1112 small cell carcinoma 9.7
1113 sleep apnea 9.7
1114 infective endocarditis 9.7
1115 simultanagnosia 9.7
1116 visual agnosia 9.7
1117 clostridium difficile colitis 9.7
1118 crohn's colitis 9.7
1119 stuttering 9.7
1120 post-cardiac arrest syndrome 9.7
1121 lymphoblastic lymphoma 9.7
1122 polycystic kidney disease 9.7
1123 tonsillitis 9.7
1124 filariasis 9.7
1125 sarcoma 9.7
1126 anhidrosis 9.7
1127 megacolon 9.7
1128 hemopericardium 9.7
1129 mitral valve insufficiency 9.7
1130 pericardial effusion 9.7
1131 esophagitis 9.7
1132 inflammatory spondylopathy 9.7
1133 filarial elephantiasis 9.7
1134 acoustic neuroma 9.7
1135 nephronophthisis 9.7
1136 transient global amnesia 9.7
1137 branch retinal artery occlusion 9.7
1138 gout 9.7
1139 neurosarcoidosis 9.7
1140 loiasis 9.7
1141 biliary atresia 9.7
1142 bipolar i disorder 9.7
1143 plasmodium falciparum malaria 9.7
1144 alcoholic neuropathy 9.7
1145 hypophosphatasia 9.7
1146 renal tubular acidosis 9.7
1147 capillary leak syndrome 9.7
1148 critical illness polyneuropathy 9.7
1149 cholera 9.7
1150 communicating hydrocephalus 9.7
1151 calcinosis 9.7
1152 enthesopathy 9.7
1153 autoimmune hepatitis 9.7
1154 spondylosis 9.7
1155 leptospirosis 9.7
1156 familial nephrotic syndrome 9.7
1157 cerebellar disease 9.7
1158 glucosephosphate dehydrogenase deficiency 9.7
1159 newcastle disease 9.7
1160 adenocarcinoma 9.7
1161 cerebritis 9.7
1162 plague 9.7
1163 mixed connective tissue disease 9.7
1164 aortic aneurysm 9.7
1165 gastric adenocarcinoma 9.7
1166 insulinoma 9.7
1167 pancreatic adenocarcinoma 9.7
1168 pseudohypoparathyroidism 9.7
1169 echolalia 9.7
1170 spindle cell sarcoma 9.7
1171 nominal aphasia 9.7
1172 rapidly progressive glomerulonephritis 9.7
1173 intrahepatic cholangiocarcinoma 9.7
1174 neurotic disorder 9.7
1175 von economo's disease 9.7
1176 blepharospasm 9.7
1177 internuclear ophthalmoplegia 9.7
1178 schizoaffective disorder 9.7
1179 nephrolithiasis 9.7
1180 lymphopenia 9.7
1181 hypersplenism 9.7
1182 spondylitis 9.7
1183 active peptic ulcer disease 9.7
1184 gastrointestinal system disease 9.7
1185 childhood leukemia 9.7
1186 polycythemia 9.7
1187 localized scleroderma 9.7
1188 retinal artery occlusion 9.7
1189 parasitic helminthiasis infectious disease 9.7
1190 achalasia 9.7
1191 exophthalmos 9.7
1192 pulmonary embolism 9.7
1193 lassa fever 9.7
1194 medium-chain acyl-coenzyme a dehydrogenase deficiency 9.7
1195 aminoaciduria 9.7
1196 broken heart syndrome 9.7
1197 chronic hiccups 9.7
1198 congenital rubella 9.7
1199 dwarfism 9.7
1200 granulocytopenia 9.7
1201 opsoclonus-myoclonus syndrome 9.7
1202 chronic pain 9.7
1203 meningitis and encephalitis 9.7
1204 balint syndrome 9.7
1205 ring chromosome 9.7
1206 idiopathic nephrotic syndrome 9.7
1207 intravascular large b-cell lymphoma 9.7
1208 episodic ataxia, type 2 9.6
1209 basal ganglia calcification, idiopathic, childhood-onset 9.6
1210 cardiac conduction defect 9.6
1211 coproporphyria, hereditary 9.6
1212 cornelia de lange syndrome 1 9.6
1213 cryoglobulinemia, familial mixed 9.6
1214 dementia, lewy body 9.6
1215 episodic kinesigenic dyskinesia 1 9.6
1216 esophageal cancer 9.6
1217 external auditory canal, bilateral atresia of, with congenital vertical talus 9.6
1218 hemifacial atrophy, progressive 9.6
1219 migraine, familial hemiplegic, 1 9.6
1220 hirschsprung disease 1 9.6
1221 intussusception 9.6
1222 kaposi sarcoma 9.6
1223 medulloblastoma 9.6
1224 myelopathy, htlv-1-associated 9.6
1225 myoclonus and ataxia 9.6
1226 episodic ataxia, type 1 9.6
1227 myositis 9.6
1228 neutrophil migration 9.6
1229 obsessive-compulsive disorder 9.6
1230 optic atrophy 1 9.6
1231 optic nerve hypoplasia, bilateral 9.6
1232 variegate porphyria 9.6
1233 retinal detachment 9.6
1234 rheumatoid arthritis 9.6
1235 tetralogy of fallot 9.6
1236 thrombocytopenic purpura, autoimmune 9.6
1237 trigeminal neuralgia 9.6
1238 suppressor of tumorigenicity 3 9.6
1239 williams-beuren syndrome 9.6
1240 abetalipoproteinemia 9.6
1241 cystic fibrosis 9.6
1242 hypouricemia, renal, 1 9.6
1243 dandy-walker syndrome 9.6
1244 lysinuric protein intolerance 9.6
1245 cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1 9.6
1246 visceral steatosis, congenital 9.6
1247 friedreich ataxia 9.6
1248 achalasia-addisonianism-alacrima syndrome 9.6
1249 multiple acyl-coa dehydrogenase deficiency 9.6
1250 goodpasture syndrome 9.6
1251 hemolytic uremic syndrome, atypical 1 9.6
1252 mowat-wilson syndrome 9.6
1253 hypoascorbemia 9.6
1254 hypothalamic hamartomas 9.6
1255 familial mediterranean fever 9.6
1256 myopathy, congenital 9.6
1257 pituitary hormone deficiency, combined, 2 9.6
1258 reticulum cell sarcoma 9.6
1259 retinitis pigmentosa 9.6
1260 thymoma, familial 9.6
1261 thyrotropin-releasing hormone deficiency 9.6
1262 werner syndrome 9.6
1263 adrenoleukodystrophy 9.6
1264 lesch-nyhan syndrome 9.6
1265 deafness, dystonia, and cerebral hypomyelination 9.6
1266 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 9.6
1267 aging 9.6
1268 gallbladder disease 1 9.6
1269 asthma 9.6
1270 migraine, familial hemiplegic, 2 9.6
1271 dermatitis, atopic 9.6
1272 ventricular fibrillation, paroxysmal familial, 1 9.6
1273 langerhans cell histiocytosis 9.6
1274 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.6
1275 abdominal obesity-metabolic syndrome 1 9.6
1276 frontotemporal lobar degeneration with tdp43 inclusions, grn-related 9.6
1277 psoriatic arthritis 9.6
1278 febrile seizures, familial, 8 9.6
1279 seizures, benign familial infantile, 3 9.6
1280 legionnaire disease 9.6
1281 severe cutaneous adverse reaction 9.6
1282 congenital disorder of glycosylation, type in 9.6
1283 lung cancer susceptibility 3 9.6
1284 microvascular complications of diabetes 5 9.6
1285 premature ovarian failure 7 9.6
1286 retinitis pigmentosa 58 9.6
1287 beta-thalassemia 9.6
1288 pyruvate dehydrogenase e1-beta deficiency 9.6
1289 muscle hypertrophy 9.6
1290 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant 9.6
1291 combined oxidative phosphorylation deficiency 14 9.6
1292 mitochondrial short-chain enoyl-coa hydratase 1 deficiency 9.6
1293 hypotonia, infantile, with psychomotor retardation and characteristic facies 2 9.6
1294 striatal degeneration, autosomal dominant 2 9.6
1295 portal hypertension, noncirrhotic 9.6
1296 mucopolysaccharidosis-plus syndrome 9.6
1297 neurodevelopmental disorder with poor language and loss of hand skills 9.6
1298 phenytoin toxicity 9.6
1299 combined oxidative phosphorylation deficiency 37 9.6
1300 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.6
1301 juvenile arthritis 9.6
1302 neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity 9.6
1303 peripheral vascular disease 9.6
1304 chikungunya 9.6
1305 rocky mountain spotted fever 9.6
1306 acute diarrhea 9.6
1307 erythema multiforme 9.6
1308 korean hemorrhagic fever 9.6
1309 hypermethioninemia 9.6
1310 intestinal schistosomiasis 9.6
1311 extrapulmonary tuberculosis 9.6
1312 abdominal tuberculosis 9.6
1313 anaplastic large cell lymphoma 9.6
1314 paraganglioma 9.6
1315 atrioventricular block 9.6
1316 oromandibular dystonia 9.6
1317 hemidystonia 9.6
1318 hemorrhagic cystitis 9.6
1319 hereditary ataxia 9.6
1320 withdrawal disorder 9.6
1321 anosognosia 9.6
1322 cortical deafness 9.6
1323 ischemic colitis 9.6
1324 paroxysmal nocturnal hemoglobinuria 9.6
1325 bone resorption disease 9.6
1326 metaphyseal dysplasia 9.6
1327 cytomegalovirus retinitis 9.6
1328 mucositis 9.6
1329 endometritis 9.6
1330 sparganosis 9.6
1331 venous insufficiency 9.6
1332 siderosis 9.6
1333 charcot-marie-tooth disease 9.6
1334 microphthalmia 9.6
1335 interstitial nephritis 9.6
1336 paragonimiasis 9.6
1337 chronic pyelonephritis 9.6
1338 methemoglobinemia 9.6
1339 tooth disease 9.6
1340 spastic hemiplegia 9.6
1341 spotted fever 9.6
1342 hydronephrosis 9.6
1343 henoch-schoenlein purpura 9.6
1344 hantavirus hemorrhagic fever with renal syndrome 9.6
1345 pituitary apoplexy 9.6
1346 cerebral arteritis 9.6
1347 constrictive pericarditis 9.6
1348 hypertensive heart disease 9.6
1349 diabetic angiopathy 9.6
1350 cornelia de lange syndrome 9.6
1351 gastroparesis 9.6
1352 conn's syndrome 9.6
1353 hemosiderosis 9.6
1354 oligohydramnios 9.6
1355 paranoid schizophrenia 9.6
1356 chronic pulmonary heart disease 9.6
1357 marasmus 9.6
1358 locked-in syndrome 9.6
1359 diabetic polyneuropathy 9.6
1360 endomyocardial fibrosis 9.6
1361 central nervous system leukemia 9.6
1362 persistent fetal circulation syndrome 9.6
1363 renal osteodystrophy 9.6
1364 kwashiorkor 9.6
1365 hepatic infarction 9.6
1366 somatization disorder 9.6
1367 poems syndrome 9.6
1368 cerebral degeneration 9.6
1369 cholesterol embolism 9.6
1370 candidiasis 9.6
1371 angioedema 9.6
1372 acute chest syndrome 9.6
1373 keratosis 9.6
1374 neuroendocrine tumor 9.6
1375 facial hemiatrophy 9.6
1376 conversion disorder 9.6
1377 toxic megacolon 9.6
1378 islet cell tumor 9.6
1379 neuroendocrine carcinoma 9.6
1380 drug-induced hepatitis 9.6
1381 ascending colon cancer 9.6
1382 generalized atherosclerosis 9.6
1383 iron metabolism disease 9.6
1384 relapsing-remitting multiple sclerosis 9.6
1385 hereditary spastic paraplegia 9.6
1386 reflex epilepsy 9.6
1387 kidney cancer 9.6
1388 benign mesothelioma 9.6
1389 transitional cell carcinoma 9.6
1390 myoma 9.6
1391 hemoglobinopathy 9.6
1392 gallbladder cancer 9.6
1393 lipid metabolism disorder 9.6
1394 lipomatosis 9.6
1395 tropical spastic paraparesis 9.6
1396 rhabdomyosarcoma 9.6
1397 thymoma 9.6
1398 osteitis fibrosa 9.6
1399 bone inflammation disease 9.6
1400 pediatric osteosarcoma 9.6
1401 histiocytosis 9.6
1402 mastocytosis 9.6
1403 pulmonary fibrosis 9.6
1404 arthropathy 9.6
1405 cranial nerve palsy 9.6
1406 restrictive cardiomyopathy 9.6
1407 bladder urothelial carcinoma 9.6
1408 ganglioneuroblastoma 9.6
1409 hypertrichosis 9.6
1410 radiculopathy 9.6
1411 intracranial embolism 9.6
1412 uremic neuropathy 9.6
1413 somatoform disorder 9.6
1414 alcoholic pancreatitis 9.6
1415 central nervous system vasculitis 9.6
1416 intestinal disease 9.6
1417 acute pyelonephritis 9.6
1418 t-cell acute lymphoblastic leukemia 9.6
1419 adult acute lymphocytic leukemia 9.6
1420 cerebral lymphoma 9.6
1421 hemoglobinuria 9.6
1422 agoraphobia 9.6
1423 conjunctivitis 9.6
1424 fibromyalgia 9.6
1425 placenta disease 9.6
1426 osteochondrosis 9.6
1427 paralytic ileus 9.6
1428 mucormycosis 9.6
1429 polyhydramnios 9.6
1430 collagen disease 9.6
1431 perinatal necrotizing enterocolitis 9.6
1432 intermediate coronary syndrome 9.6
1433 autosomal dominant polycystic kidney disease 9.6
1434 narcolepsy 9.6
1435 peroxisomal disease 9.6
1436 erythromelalgia 9.6
1437 scotoma 9.6
1438 postpartum depression 9.6
1439 stomatitis 9.6
1440 diabetic neuropathy 9.6
1441 trichinosis 9.6
1442 congenital syphilis 9.6
1443 miliary tuberculosis 9.6
1444 hypoplastic left heart syndrome 9.6
1445 hyperphenylalaninemia 9.6
1446 atp1a3-related neurologic disorders 9.6
1447 bap1 tumor predisposition syndrome 9.6
1448 clpb deficiency 9.6
1449 fumarate hydratase deficiency 9.6
1450 kcnt1-related epilepsy 9.6
1451 tubulinopathies 9.6
1452 unc80 deficiency 9.6
1453 acute articular rheumatism 9.6
1454 adrenomyeloneuropathy 9.6
1455 cerebrospinal fluid leak 9.6
1456 chiari malformation 9.6
1457 chronic graft versus host disease 9.6
1458 congenital cytomegalovirus 9.6
1459 congenital hydrocephalus 9.6
1460 distal renal tubular acidosis 9.6
1461 gigantism 9.6
1462 growth hormone deficiency 9.6
1463 haemophilus influenzae 9.6
1464 handl syndrome 9.6
1465 htlv-1 associated myelopathy/tropical spastic paraparesis 9.6
1466 hypocomplementemic urticarial vasculitis 9.6
1467 mast cell activation syndrome 9.6
1468 mercury poisoning 9.6
1469 new-onset refractory status epilepticus 9.6
1470 post-transplant lymphoproliferative disease 9.6
1471 rasmussen johnsen thomsen syndrome 9.6
1472 ring chromosome 20 9.6
1473 raynaud phenomenon 9.6
1474 sporadic hemiplegic migraine 9.6
1475 back pain 9.6
1476 pituitary tumors 9.6
1477 whiplash 9.6
1478 cryptogenic late-onset epileptic spasms 9.6
1479 myoclonic-astastic epilepsy 9.6
1480 familial or sporadic hemiplegic migraine 9.6
1481 superficial siderosis 9.6
1482 pulmonary arterial hypertension associated with portal hypertension 9.6
1483 unilateral polymicrogyria 9.6
1484 muscular lipidosis 9.6
1485 rasmussen subacute encephalitis 9.6
1486 manganese poisoning 9.6
1487 exercise-induced malignant hyperthermia 9.6
1488 hypotonia-speech impairment-severe cognitive delay syndrome 9.6
1489 postpartum psychosis 9.6
1490 erythema multiforme major 9.6
1491 methanol poisoning 9.6
1492 methotrexate toxicity 9.6
1493 neurometabolic disease 9.6
1494 transient pseudohypoaldosteronism 9.6
1495 postinfectious encephalitis 9.6
1496 cardiogenic shock 9.6
1497 acute adrenal insufficiency 9.6
1498 benign childhood occipital epilepsy, panayiotopoulos type 9.6
1499 rare epilepsy 9.6
1500 abducens palsy 9.5
1501 acanthosis nigricans 9.5
1502 neurofibromatosis, type ii 9.5
1503 alopecia, psychomotor epilepsy, pyorrhea, and mental subnormality 9.5
1504 aplasia cutis congenita, nonsyndromic 9.5
1505 machado-joseph disease 9.5
1506 blepharophimosis, ptosis, and epicanthus inversus 9.5
1507 blue rubber bleb nevus 9.5
1508 progressive familial heart block, type ia 9.5
1509 carcinoid tumors, intestinal 9.5
1510 centralopathic epilepsy 9.5
1511 sotos syndrome 1 9.5
1512 cerebrocostomandibular syndrome 9.5
1513 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 9.5
1514 dyschromatosis symmetrica hereditaria 9.5
1515 erythroleukemia, familial 9.5
1516 gilles de la tourette syndrome 9.5
1517 hair whorl 9.5
1518 hand skill, relative 9.5
1519 diaphragmatic hernia, congenital 9.5
1520 hypertelorism 9.5
1521 ige responsiveness, atopic 9.5
1522 laryngomalacia 9.5
1523 leiomyoma, uterine 9.5
1524 leukemia, acute monocytic 9.5
1525 leukemia, chronic lymphocytic 9.5
1526 thyroid carcinoma, familial medullary 9.5
1527 mesomelic dysplasia, kantaputra type 9.5
1528 metaphyseal chondrodysplasia, schmid type 9.5
1529 facioscapulohumeral muscular dystrophy 1 9.5
1530 amyotrophy, hereditary neuralgic 9.5
1531 neurofibromatosis, type i 9.5
1532 night blindness, congenital stationary, autosomal dominant 2 9.5
1533 noonan syndrome 1 9.5
1534 optic atrophy 3, autosomal dominant 9.5
1535 palmomental reflex 9.5
1536 papillomatosis, confluent and reticulated 9.5
1537 pemphigus vulgaris, familial 9.5
1538 pernicious anemia 9.5
1539 phosphatase, acid, of tissues 9.5
1540 polykaryocytosis inducer 9.5
1541 prostate cancer 9.5
1542 dowling-degos disease 1 9.5
1543 schizophrenia 1 9.5
1544 septooptic dysplasia 9.5
1545 sneddon syndrome 9.5
1546 spinal arachnoiditis 9.5
1547 spinocerebellar ataxia 6 9.5
1548 spondylolisthesis 9.5
1549 telangiectasia, hereditary hemorrhagic, type 1 9.5
1550 thyroid cancer, nonmedullary, 1 9.5
1551 vesicoureteral reflux 1 9.5
1552 vitiligo-associated multiple autoimmune disease susceptibility 6 9.5
1553 von hippel-lindau syndrome 9.5
1554 wilms tumor 1 9.5
1555 choreoacanthocytosis 9.5
1556 acth deficiency, isolated 9.5
1557 acyl-coa dehydrogenase, short-chain, deficiency of 9.5
1558 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.5
1559 adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency 9.5
1560 glucocorticoid deficiency 1 9.5
1561 adrenocortical carcinoma, hereditary 9.5
1562 alaninuria with microcephaly, dwarfism, enamel hypoplasia, and diabetes mellitus 9.5
1563 alpha-methylacetoacetic aciduria 9.5
1564 ceroid lipofuscinosis, neuronal, 3 9.5
1565 amyotonia congenita 9.5
1566 anemia, autoimmune hemolytic 9.5
1567 anemia, hypochromic microcytic, with iron overload 1 9.5
1568 apolipoprotein c-ii deficiency 9.5
1569 arachnoid cysts, intracranial 9.5
1570 ascites, chylous 9.5
1571 ataxia-telangiectasia 9.5
1572 australia antigen 9.5
1573 3-methylcrotonyl-coa carboxylase 2 deficiency 9.5
1574 carnitine deficiency, myopathic 9.5
1575 cerebellar vermis aplasia with associated features suggesting smith-lemli-opitz syndrome and meckel syndrome 9.5
1576 joubert syndrome 1 9.5
1577 basal ganglia calcification, idiopathic, 1 9.5
1578 bile acid synthesis defect, congenital, 4 9.5
1579 convulsive disorder, familial, with prenatal or early onset 9.5
1580 corpus callosum, agenesis of 9.5
1581 cryptorchidism, unilateral or bilateral 9.5
1582 d-glyceric aciduria 9.5
1583 deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome 9.5
1584 dubowitz syndrome 9.5
1585 duodenal atresia 9.5
1586 dysosteosclerosis 9.5
1587 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.5
1588 eosinophilic fasciitis 9.5
1589 factor vii deficiency 9.5
1590 factor x deficiency 9.5
1591 fanconi anemia, complementation group a 9.5
1592 3-hydroxyacyl-coa dehydrogenase deficiency 9.5
1593 glycogen storage disease v 9.5
1594 hyperphenylalaninemia, bh4-deficient, b 9.5
1595 neurodegeneration with brain iron accumulation 1 9.5
1596 halothane hepatitis 9.5
1597 hartnup disorder 9.5
1598 histidinemia 9.5
1599 hydrocephalus due to congenital stenosis of aqueduct of sylvius 9.5
1600 muscular dystrophy-dystroglycanopathy , type a, 1 9.5
1601 hydrops fetalis, nonimmune 9.5
1602 hydroxyprolinemia 9.5
1603 hyperlexia 9.5
1604 hyperlipoproteinemia, type i 9.5
1605 hypoadrenocorticism, familial 9.5
1606 acetylation, slow 9.5
1607 jejunal atresia 9.5
1608 krabbe disease 9.5
1609 mitochondrial dna depletion syndrome 9 9.5
1610 dihydrolipoamide dehydrogenase deficiency 9.5
1611 lipoid proteinosis of urbach and wiethe 9.5
1612 lymphoid interstitial pneumonia 9.5
1613 macrocephaly/megalencephaly syndrome, autosomal recessive 9.5
1614 malonyl-coa decarboxylase deficiency 9.5
1615 mannosidosis, beta a, lysosomal 9.5
1616 megacystis-microcolon-intestinal hypoperistalsis syndrome 9.5
1617 thiamine-responsive megaloblastic anemia syndrome 9.5
1618 metachromatic leukodystrophy 9.5
1619 3-methylglutaconic aciduria, type iv 9.5
1620 methylmalonic aciduria, cblb type 9.5
1621 microcolon 9.5
1622 holocarboxylase synthetase deficiency 9.5
1623 spinal muscular atrophy, type i 9.5
1624 epilepsy, progressive myoclonic, 4, with or without renal failure 9.5
1625 proteasome-associated autoinflammatory syndrome 1 9.5
1626 neuraminidase deficiency 9.5
1627 neurodegeneration with brain iron accumulation 2a 9.5
1628 ceroid lipofuscinosis, neuronal, 1 9.5
1629 oliver syndrome 9.5
1630 optic atrophy 6 9.5
1631 5-oxoprolinase deficiency 9.5
1632 pancreatic agenesis 1 9.5
1633 phenylketonuria 9.5
1634 hyperphenylalaninemia, bh4-deficient, c 9.5
1635 polycystic kidney disease 4 with or without polycystic liver disease 9.5
1636 polycythemia vera 9.5
1637 pseudoxanthoma elasticum 9.5
1638 pyle disease 9.5
1639 senior-loken syndrome 1 9.5
1640 sandhoff disease 9.5
1641 schinzel-giedion midface retraction syndrome 9.5
1642 sjogren syndrome 9.5
1643 striatonigral degeneration, infantile 9.5
1644 succinic semialdehyde dehydrogenase deficiency 9.5
1645 multiple sulfatase deficiency 9.5
1646 tardive dyskinesia 9.5
1647 raynaud-claes syndrome 9.5
1648 ectodermal dysplasia and immunodeficiency 1 9.5
1649 fragile x syndrome 9.5
1650 rolandic epilepsy, mental retardation, and speech dyspraxia, x-linked 9.5
1651 alpha-thalassemia/mental retardation syndrome, x-linked 9.5
1652 fabry disease 9.5
1653 barth syndrome 9.5
1654 nance-horan syndrome 9.5
1655 hemophilia a 9.5
1656 menkes disease 9.5
1657 muscular dystrophy, duchenne type 9.5
1658 otopalatodigital syndrome, type i 9.5
1659 deafness, nonsyndromic sensorineural, mitochondrial 9.5
1660 mitochondrial complex v deficiency, mitochondrial type 1 9.5
1661 neuropathy, ataxia, and retinitis pigmentosa 9.5
1662 exstrophy of bladder 9.5
1663 spinocerebellar ataxia 4 9.5
1664 carnitine palmitoyltransferase ii deficiency, infantile 9.5
1665 fryns microphthalmia syndrome 9.5
1666 severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative 9.5
1667 timothy syndrome 9.5
1668 suppression of tumorigenicity 12 9.5
1669 wilms tumor 5 9.5
1670 preaxial hallucal polydactyly 9.5
1671 pallister-killian syndrome 9.5
1672 autoimmune lymphoproliferative syndrome 9.5
1673 convulsions, familial infantile, with paroxysmal choreoathetosis 9.5
1674 gracile syndrome 9.5
1675 congenital disorder of glycosylation, type iif 9.5
1676 leukoencephalopathy with vanishing white matter 9.5
1677 microvascular complications of diabetes 1 9.5
1678 megalencephalic leukoencephalopathy with subcortical cysts 1 9.5
1679 alpha-thalassemia 9.5
1680 generalized epilepsy with febrile seizures plus, type 1 9.5
1681 salla disease 9.5
1682 orthostatic intolerance 9.5
1683 carnitine acetyltransferase deficiency 9.5
1684 vitiligo-associated multiple autoimmune disease susceptibility 1 9.5
1685 polysubstance abuse 9.5
1686 aortic aneurysm, familial thoracic 1 9.5
1687 asthma-related traits 1 9.5
1688 gaze palsy, familial horizontal, with progressive scoliosis 1 9.5
1689 coronary heart disease 1 9.5
1690 breath-holding spells 9.5
1691 chromosome 1p36 deletion syndrome 9.5
1692 mycobacterium tuberculosis 1 9.5
1693 endometrial cancer 9.5
1694 slowed nerve conduction velocity, autosomal dominant 9.5
1695 parathyroid carcinoma 9.5
1696 aromatic l-amino acid decarboxylase deficiency 9.5
1697 severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive 9.5
1698 charcot-marie-tooth disease, axonal, autosomal dominant, type 2a2a 9.5
1699 alzheimer disease 11 9.5
1700 spastic paraplegia 30, autosomal dominant 9.5
1701 mevalonic aciduria 9.5
1702 combined oxidative phosphorylation deficiency 2 9.5
1703 chromosome 16p13.3 deletion syndrome, proximal 9.5
1704 major affective disorder 5 9.5
1705 major affective disorder 6 9.5
1706 ectodermal dysplasia and immunodeficiency 2 9.5
1707 colorectal cancer 6 9.5
1708 acute promyelocytic leukemia 9.5
1709 multiple sclerosis 4 9.5
1710 microvascular complications of diabetes 2 9.5
1711 cerebral creatine deficiency syndrome 2 9.5
1712 hearing loss, noise-induced 9.5
1713 neurodegeneration due to cerebral folate transport deficiency 9.5
1714 muscular dystrophy, congenital, lmna-related 9.5
1715 charcot-marie-tooth disease, axonal, type 2n 9.5
1716 mental retardation, autosomal dominant 20 9.5
1717 c1q deficiency 9.5
1718 beaulieu-boycott-innes syndrome 9.5
1719 obesity, hyperphagia, and developmental delay 9.5
1720 nescav syndrome 9.5
1721 cognitive impairment with or without cerebellar ataxia 9.5
1722 membranous nephropathy 9.5
1723 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 9.5
1724 human herpesvirus 8 9.5
1725 combined oxidative phosphorylation deficiency 11 9.5
1726 congenital disorder of glycosylation, type iu 9.5
1727 mitochondrial complex v deficiency, nuclear type 4 9.5
1728 multiple mitochondrial dysfunctions syndrome 3 9.5
1729 schaaf-yang syndrome 9.5
1730 myopathy with extrapyramidal signs 9.5
1731 pontocerebellar hypoplasia, type 2e 9.5
1732 tatton-brown-rahman syndrome 9.5
1733 combined oxidative phosphorylation deficiency 20 9.5
1734 glucocorticoid resistance, generalized 9.5
1735 combined oxidative phosphorylation deficiency 23 9.5
1736 optic atrophy 9 9.5
1737 metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration 9.5
1738 hypotonia, infantile, with psychomotor retardation and characteristic facies 3 9.5
1739 mental retardation, autosomal dominant 42 9.5
1740 hydrops, lactic acidosis, and sideroblastic anemia 9.5
1741 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 9.5
1742 mental retardation, autosomal dominant 46 9.5
1743 3-methylglutaconic aciduria, type ix 9.5
1744 neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 9.5
1745 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive 9.5
1746 mental retardation, autosomal dominant 55, with seizures 9.5
1747 developmental delay and seizures with or without movement abnormalities 9.5
1748 mental retardation, autosomal dominant 56 9.5
1749 leukodystrophy, hypomyelinating, 14 9.5
1750 epilepsy, familial focal, with variable foci 4 9.5
1751 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 9.5
1752 neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 9.5
1753 glycosylphosphatidylinositol biosynthesis defect 18 9.5
1754 brain abnormalities, neurodegeneration, and dysosteosclerosis 9.5
1755 generalized epilepsy with febrile seizures plus, type 10 9.5
1756 microangiopathy and leukoencephalopathy, pontine, autosomal dominant 9.5
1757 intellectual developmental disorder 60 with seizures 9.5
1758 congenital methemoglobinemia 9.5
1759 stargardt disease 9.5
1760 adrenal cortical carcinoma 9.5
1761 african tick-bite fever 9.5
1762 invasive aspergillosis 9.5
1763 dengue shock syndrome 9.5
1764 tick-borne encephalitis 9.5
1765 powassan encephalitis 9.5
1766 swine influenza 9.5
1767 lambert-eaton myasthenic syndrome 9.5
1768 coenurosis 9.5
1769 angiostrongyliasis 9.5
1770 congenital hypothyroidism 9.5
1771 carrion's disease 9.5
1772 restless legs syndrome 9.5
1773 asperger syndrome 9.5
1774 brugada syndrome 9.5
1775 loeys-dietz syndrome 9.5
1776 multinodular goiter 9.5
1777 adult t-cell leukemia 9.5
1778 hereditary sensory neuropathy 9.5
1779 walker-warburg syndrome 9.5
1780 congenital generalized lipodystrophy 9.5
1781 severe congenital neutropenia 9.5
1782 hypochromic microcytic anemia 9.5
1783 distal arthrogryposis 9.5
1784 fetal alcohol syndrome 9.5
1785 alcohol-related birth defect 9.5
1786 3-methylcrotonyl-coa carboxylase deficiency 9.5
1787 mantle cell lymphoma 9.5
1788 non-syndromic x-linked intellectual disability 9.5
1789 secondary progressive multiple sclerosis 9.5
1790 biotin deficiency 9.5
1791 first-degree atrioventricular block 9.5
1792 fibroma 9.5
1793 spastic ataxia 9.5
1794 sexual disorder 9.5
1795 cutaneous t cell lymphoma 9.5
1796 marantic endocarditis 9.5
1797 brain glioma 9.5
1798 finger agnosia 9.5
1799 diffuse alopecia areata 9.5
1800 body dysmorphic disorder 9.5
1801 balo concentric sclerosis 9.5
1802 atrial fibrillation 9.5
1803 adams-oliver syndrome 9.5
1804 omphalocele 9.5
1805 anal fistula 9.5
1806 zika fever 9.5
1807 early-onset parkinson's disease 9.5
1808 autosomal dominant non-syndromic intellectual disability 5 9.5
1809 miyoshi muscular dystrophy 9.5
1810 obstructive nephropathy 9.5
1811 congenital fiber-type disproportion 9.5
1812 thyroid gland anaplastic carcinoma 9.5
1813 coronavirus infectious disease 9.5
1814 bone sarcoma 9.5
1815 diffuse midline glioma, h3 k27m-mutant 9.5
1816 aortic dissection 9.5
1817 rasopathy 9.5
1818 galloway-mowat syndrome 9.5
1819 alpha thalassemia-x-linked intellectual disability syndrome 9.5
1820 angioimmunoblastic t-cell lymphoma 9.5
1821 gastric leiomyoma 9.5
1822 pigmentation disease 9.5
1823 optic papillitis 9.5
1824 cholelithiasis 9.5
1825 brown's tendon sheath syndrome 9.5
1826 ehrlichiosis 9.5
1827 louping ill 9.5
1828 left bundle branch hemiblock 9.5
1829 monocular esotropia 9.5
1830 parotitis 9.5
1831 viral meningitis 9.5
1832 chronic leukemia 9.5
1833 suppression amblyopia 9.5
1834 amblyopia 9.5
1835 amyotrophic neuralgia 9.5
1836 gastric lymphoma 9.5
1837 microinvasive gastric cancer 9.5
1838 lactose intolerance 9.5
1839 separation anxiety disorder 9.5
1840 mastitis 9.5
1841 mesenteric lymphadenitis 9.5
1842 partial third-nerve palsy 9.5
1843 abducens nerve disease 9.5
1844 borderline personality disorder 9.5
1845 dissociative disorder 9.5
1846 strongyloidiasis 9.5
1847 alport syndrome 9.5
1848 placenta praevia 9.5
1849 bartonellosis 9.5
1850 prostatic hypertrophy 9.5
1851 t cell deficiency 9.5
1852 vitamin k deficiency bleeding 9.5
1853 ornithosis 9.5
1854 plummer's disease 9.5
1855 retinal microaneurysm 9.5
1856 pneumocystosis 9.5
1857 gnathomiasis 9.5
1858 subdural empyema 9.5
1859 cardiac tamponade 9.5
1860 rumination disorder 9.5
1861 chondrocalcinosis 9.5
1862 iron deficiency anemia 9.5
1863 protein-energy malnutrition 9.5
1864 coronary artery vasospasm 9.5
1865 mononeuropathy 9.5
1866 dysthymic disorder 9.5
1867 chagas disease 9.5
1868 detrusor sphincter dyssynergia 9.5
1869 alveolar echinococcosis 9.5
1870 arachnoiditis 9.5
1871 plica syndrome 9.5
1872 retroperitoneal sarcoma 9.5
1873 complex partial epilepsy 9.5
1874 dysentery 9.5
1875 secondary hyperparathyroidism 9.5
1876 dyscalculia 9.5
1877 neonatal thyrotoxicosis 9.5
1878 blastomycosis 9.5
1879 nephrocalcinosis 9.5
1880 respiratory syncytial virus infectious disease 9.5
1881 migraine without aura 9.5
1882 ocular motility disease 9.5
1883 thyroid crisis 9.5
1884 crescentic glomerulonephritis 9.5
1885 dissociated nystagmus 9.5
1886 brain cancer 9.5
1887 nodular goiter 9.5
1888 mycoplasma pneumoniae pneumonia 9.5
1889 reading disorder 9.5
1890 pulmonary sarcoidosis 9.5
1891 extrahepatic cholestasis 9.5
1892 post-vaccinal encephalitis 9.5
1893 achromatopsia 9.5
1894 peptic esophagitis 9.5
1895 autoimmune polyendocrine syndrome 9.5
1896 acute diffuse nephritis 9.5
1897 anus cancer 9.5
1898 adult-onset still's disease 9.5
1899 oral candidiasis 9.5
1900 generalized anxiety disorder 9.5
1901 pyuria 9.5
1902 gonadal dysgenesis 9.5
1903 neuronal ceroid lipofuscinosis 9.5
1904 foster-kennedy syndrome 9.5
1905 olivopontocerebellar atrophy 9.5
1906 echinococcosis 9.5
1907 panniculitis 9.5
1908 urticaria 9.5
1909 hypersensitivity reaction type iii disease 9.5
1910 rheumatic fever 9.5
1911 thrombocytopenia due to platelet alloimmunization 9.5
1912 endogenous depression 9.5
1913 central nervous system tuberculosis 9.5
1914 neovascular glaucoma 9.5
1915 ichthyosis 9.5
1916 duodenal ulcer 9.5
1917 histoplasmosis 9.5
1918 squamous cell carcinoma 9.5
1919 factitious disorder 9.5
1920 peritoneal mesothelioma 9.5
1921 impotence 9.5
1922 sphingolipidosis 9.5
1923 bardet-biedl syndrome 9.5
1924 ectodermal dysplasia 9.5
1925 urogenital tuberculosis 9.5
1926 amelogenesis imperfecta 9.5
1927 essential thrombocythemia 9.5
1928 myeloproliferative neoplasm 9.5
1929 thrombocytosis 9.5
1930 basilar artery insufficiency 9.5
1931 pharyngitis 9.5
1932 colon adenocarcinoma 9.5
1933 craniosynostosis 9.5
1934 monoclonal paraproteinemia 9.5
1935 macrocytic anemia 9.5
1936 west nile encephalitis 9.5
1937 retinal vascular disease 9.5
1938 motor peripheral neuropathy 9.5
1939 basal cell carcinoma 9.5
1940 hemangioma 9.5
1941 granulomatous angiitis 9.5
1942 relapsing polychondritis 9.5
1943 larynx cancer 9.5
1944 pancreas disease 9.5
1945 papillary serous adenocarcinoma 9.5
1946 synovitis 9.5
1947 acrodermatitis 9.5
1948 epidermolysis bullosa 9.5
1949 glycogen storage disease 9.5
1950 bronchiolitis obliterans 9.5
1951 acalculous cholecystitis 9.5
1952 cervix carcinoma 9.5
1953 iga glomerulonephritis 9.5
1954 testicular cancer 9.5
1955 serous cystadenocarcinoma 9.5
1956 multiple endocrine neoplasia 9.5
1957 scleredema adultorum 9.5
1958 nemaline myopathy 9.5
1959 lysosomal storage disease 9.5
1960 aspiration pneumonitis 9.5
1961 lipid pneumonia 9.5
1962 thymic carcinoma 9.5
1963 vaccinia 9.5
1964 germinoma 9.5
1965 glycoproteinosis 9.5
1966 fibrosarcoma 9.5
1967 bacterial vaginosis 9.5
1968 carotid artery disease 9.5
1969 carotid artery thrombosis 9.5
1970 systemic mastocytosis 9.5
1971 turner syndrome 9.5
1972 brain stem infarction 9.5
1973 middle cerebral artery infarction 9.5
1974 superior mesenteric artery syndrome 9.5
1975 central nervous system cancer 9.5
1976 intermittent claudication 9.5
1977 anal canal adenocarcinoma 9.5
1978 skin disease 9.5
1979 plasmacytoma 9.5
1980 hermansky-pudlak syndrome 9.5
1981 protein c deficiency 9.5
1982 pituitary adenoma 9.5
1983 craniopharyngioma 9.5
1984 placental insufficiency 9.5
1985 pelvic lipomatosis 9.5
1986 acute myocarditis 9.5
1987 adrenal cortical adenocarcinoma 9.5
1988 thyroid gland medullary carcinoma 9.5
1989 linitis plastica 9.5
1990 intracranial thrombosis 9.5
1991 brain stem glioma 9.5
1992 hair disease 9.5
1993 tinea capitis 9.5
1994 myofibroma 9.5
1995 dyslexia 9.5
1996 clear cell renal cell carcinoma 9.5
1997 persian gulf syndrome 9.5
1998 avian influenza 9.5
1999 ideomotor apraxia 9.5
2000 multiple chemical sensitivity 9.5
2001 proliferative glomerulonephritis 9.5
2002 diffuse glomerulonephritis 9.5
2003 colorado tick fever 9.5
2004 lymph node tuberculosis 9.5
2005 tubular adenocarcinoma 9.5
2006 epidermolysis bullosa dystrophica 9.5
2007 prosopagnosia 9.5
2008 copper deficiency myelopathy 9.5
2009 nutritional deficiency disease 9.5
2010 borna disease 9.5
2011 acute hemorrhagic encephalitis 9.5
2012 pituitary gland disease 9.5
2013 lung oat cell carcinoma 9.5
2014 eye disease 9.5
2015 silent myocardial infarction 9.5
2016 brown-sequard syndrome 9.5
2017 adrenal adenoma 9.5
2018 cerebral angioma 9.5
2019 spinal stenosis 9.5
2020 fibrillary astrocytoma 9.5
2021 bilateral breast cancer 9.5
2022 juvenile pilocytic astrocytoma 9.5
2023 hepatoblastoma 9.5
2024 subacute thyroiditis 9.5
2025 meningothelial meningioma 9.5
2026 anthrax disease 9.5
2027 delusional disorder 9.5
2028 whipple disease 9.5
2029 actinomycosis 9.5
2030 arthritis 9.5
2031 fundus dystrophy 9.5
2032 bullous pemphigoid 9.5
2033 monocytic leukemia 9.5
2034 reticulosarcoma 9.5
2035 multiple carboxylase deficiency 9.5
2036 oral cavity cancer 9.5
2037 recurrent hypersomnia 9.5
2038 myeloid sarcoma 9.5
2039 erythema infectiosum 9.5
2040 fascioliasis 9.5
2041 dermatophytosis 9.5
2042 atrophic gastritis 9.5
2043 evans' syndrome 9.5
2044 hepatopulmonary syndrome 9.5
2045 zellweger syndrome 9.5
2046 pemphigus 9.5
2047 waardenburg's syndrome 9.5
2048 ocular hypertension 9.5
2049 priapism 9.5
2050 carotid artery dissection 9.5
2051 status asthmaticus 9.5
2052 iridocyclitis 9.5
2053 acute myocardial infarction 9.5
2054 chronic cholangitis 9.5
2055 plasma cell leukemia 9.5
2056 bronchiectasis 9.5
2057 fasciitis 9.5
2058 pulmonary emphysema 9.5
2059 heart aneurysm 9.5
2060 hypersensitivity vasculitis 9.5
2061 neonatal abstinence syndrome 9.5
2062 esotropia 9.5
2063 lingual-facial-buccal dyskinesia 9.5
2064 hydrocele 9.5
2065 drug dependence 9.5
2066 eosinophilia-myalgia syndrome 9.5
2067 albinism 9.5
2068 factor v leiden thrombophilia 9.5
2069 hemophilia 9.5
2070 myotonic dystrophy 9.5
2071 nonsyndromic deafness 9.5
2072 15q duplication syndrome and related disorders 9.5
2073 bcl11a-related intellectual disability 9.5
2074 charcot-marie-tooth hereditary neuropathy 9.5
2075 classic galactosemia and clinical variant galactosemia 9.5
2076 creatine deficiency syndromes 9.5
2077 dystonia/parkinsonism, hypermanganesemia, polycythemia, and chronic liver disease 9.5
2078 gtp cyclohydrolase 1-deficient dopa-responsive dystonia 9.5
2079 mbd5 haploinsufficiency 9.5
2080 polg-related disorders 9.5
2081 rrm2b-related mitochondrial disease 9.5
2082 slc39a14 deficiency 9.5
2083 trio-related intellectual disability 9.5
2084 acute monoblastic leukemia 9.5
2085 al amyloidosis 9.5
2086 aluminosis 9.5
2087 antisynthetase syndrome 9.5
2088 auditory neuropathy spectrum disorder 9.5
2089 auriculo-condylar syndrome 9.5
2090 autoimmune autonomic ganglionopathy 9.5
2091 autoimmune myocarditis 9.5
2092 baroreflex failure 9.5
2093 brittle diabetes 9.5
2094 bronchopulmonary dysplasia 9.5
2095 carcinoid syndrome 9.5
2096 central congenital hypothyroidism 9.5
2097 charles bonnet syndrome 9.5
2098 chromosomal triplication 9.5
2099 chronic active epstein-barr virus infection 9.5
2100 congenital contractures 9.5
2101 congenital hepatic fibrosis 9.5
2102 congenital muscular dystrophy due to dystroglycanopathy 9.5
2103 congenital nonhemolytic jaundice 9.5
2104 cough headache 9.5
2105 diffuse cutaneous systemic sclerosis 9.5
2106 dipsogenic diabetes insipidus 9.5
2107 drug reaction with eosinophilia and systemic symptoms 9.5
2108 early-onset, autosomal dominant alzheimer disease 9.5
2109 erythrokeratoderma ''en cocardes'' 9.5
2110 fasting hypoglycemia 9.5
2111 fetal methylmercury syndrome 9.5
2112 fibrocartilaginous embolism 9.5
2113 gangliosidosis 9.5
2114 germ cells tumors 9.5
2115 gnathostoma infection 9.5
2116 hereditary amyloidosis 9.5
2117 hip subluxation 9.5
2118 hypertrophic olivary degeneration 9.5
2119 hypoganglionosis 9.5
2120 klebsiella infection 9.5
2121 linear scleroderma 9.5
2122 mallory-weiss syndrome 9.5
2123 meningococcemia 9.5
2124 meningoencephalocele 9.5
2125 methylmalonic acidemia with homocystinuria 9.5
2126 microscopic polyangiitis 9.5
2127 multifocal motor neuropathy 9.5
2128 muscle eye brain disease 9.5
2129 myalgic encephalomyelitis/chronic fatigue syndrome 9.5
2130 non-a-e hepatitis 9.5
2131 ovarian epithelial cancer 9.5
2132 paraneoplastic cerebellar degeneration 9.5
2133 pediatric multiple sclerosis 9.5
2134 plagiocephaly 9.5
2135 progressive encephalomyelitis with rigidity and myoclonus 9.5
2136 pseudo-turner syndrome 9.5
2137 retroperitoneal fibrosis 9.5
2138 single ventricular heart 9.5
2139 staphylococcal toxic shock syndrome 9.5
2140 stenotrophomonas maltophilia infection 9.5
2141 stevens-johnson syndrome/toxic epidermal necrolysis 9.5
2142 symmetrical thalamic calcifications 9.5
2143 systemic onset juvenile idiopathic arthritis 9.5
2144 thyrotoxic periodic paralysis 9.5
2145 trichothiodystrophy 9.5
2146 uterine sarcoma 9.5
2147 virus associated hemophagocytic syndrome 9.5
2148 weber syndrome 9.5
2149 west nile virus infection 9.5
2150 childhood myocerebrohepatopathy spectrum 9.5
2151 intranuclear rod myopathy 9.5
2152 juvenile primary osteoporosis 9.5
2153 opioid addiction 9.5
2154 aids - neurological complications 9.5
2155 foot drop 9.5
2156 megalencephaly 9.5
2157 mucolipidoses 9.5
2158 mucopolysaccharidoses 9.5
2159 myotonia 9.5
2160 neuronal migration disorders 9.5
2161 paroxysmal choreoathetosis 9.5
2162 postherpetic neuralgia 9.5
2163 psychogenic movement 9.5
2164 shaken baby syndrome 9.5
2165 spinocerebellar atrophy 9.5
2166 swallowing disorders 9.5
2167 startle epilepsy 9.5
2168 paraneoplastic limbic encephalitis 9.5
2169 non-herpetic acute limbic encephalitis 9.5
2170 multicystic dysplastic kidney 9.5
2171 primary cutaneous diffuse large b-cell lymphoma, leg type 9.5
2172 cerebellar malformation 9.5
2173 rare neurodegenerative disease 9.5
2174 progeroid syndrome 9.5
2175 acute transverse myelitis 9.5
2176 endotheliitis 9.5
2177 hemophagocytic syndrome associated with an infection 9.5
2178 secondary hemophagocytic lymphohistiocytosis 9.5
2179 inflammatory myopathy with abundant macrophages 9.5
2180 kenny-caffey syndrome 9.5
2181 high-grade astrocytoma 9.5
2182 isolated atp synthase deficiency 9.5
2183 autosomal dominant progressive external ophthalmoplegia 9.5
2184 intermediate maple syrup urine disease 9.5
2185 x-linked intellectual disability-epilepsy syndrome 9.5
2186 bilateral polymicrogyria 9.5
2187 spasmus nutans 9.5
2188 muscular glycogenosis 9.5
2189 periodic paralysis 9.5
2190 paraneoplastic sensory ganglionopathy 9.5
2191 rare venous malformation 9.5
2192 rare hereditary hemochromatosis 9.5
2193 sporadic infantile bilateral striatal necrosis 9.5
2194 early-onset generalized limb-onset dystonia 9.5
2195 acute sensory ataxic neuropathy 9.5
2196 cerebral sinovenous thrombosis 9.5
2197 qualitative or quantitative defects of alpha-dystroglycan 9.5
2198 sporadic hyperekplexia 9.5
2199 disorder of galactose metabolism 9.5
2200 paracetamol poisoning 9.5
2201 scorpion envenomation 9.5
2202 chronic enteropathy associated with slco2a1 gene 9.5
2203 ferro-cerebro-cutaneous syndrome 9.5
2204 osteonecrosis of the jaw 9.5
2205 spontaneous intracranial hypotension 9.5
2206 digitalis poisoning 9.5
2207 ethylene glycol poisoning 9.5